Website intended for a New Zealand health professional readership
2017 | 2016 | 2015 | 2014
2 August 2017
Practice
OCCUPATIONAL MEDICINE: The circular logic of complex regional pain syndrome
1. Village J, Rempel D, Teschke K. Musculoskeletal disorders of the upper extremity associated with computer work: a systematic review. Occup Ergonomics 2005;5:205–18.
HOW TO TREAT: Perimenopausal symptoms
1. Gold EB. The timing of the age at which natural menopause occurs. Obstet Gynecol Clin North Am 2011;38(3):425–40.
2. Hale GE, Burger HG. Hormonal changes and biomarkers in late reproductive age, menopausal transition and menopause. Best Pract Res Clin Obstet Gynaecol 2009;23(1):7–23.
3. Santoro N, Brown JR, Adel T et al. Characterization of reproductive hormonal dynamics in the perimenopause. J Clin Endocrinol Metab 1996;81(4):1495–501.
4. Freeman EW, Sammel MD, Lin H et al. Symptoms associated with menopausal transition and reproductive hormones in midlife women. Obstet Gynecol 2007;110(2 Pt 1):230–40.
5. Bromberger JT, Matthews KA, Schott LL et al. Depressive symptoms during the menopausal transition: the Study of Women's Health Across the Nation (SWAN). J Affect Disord 2007;103(1-3):267–72.
6. Guthrie JR, Dennerstein L, Taffe JR et al. Health care-seeking for menopausal problems. Climacteric 2003;6(2):112–17.
7. Greendale GA, Huang MH, Wight RG et al. Effects of the menopause transition and hormone use on cognitive performance in midlife women. Neurology 2009;72(21):1850–57.
8. Avis NE, Crawford SL, Greendale G et al. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med 2015;175(4):531–39.
9. Reed SD, Lampe JW, Qu C et al. Premenopausal vasomotor symptoms in an ethnically diverse population. Menopause 2014;21(2):153–58.
10. Randolph JF Jr, Sowers M, Bondarenko I et al. The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition. J Clin Endocrinol Metab 2005;90(11):6106–12.
11. Kravitz HM, Ganz PA, Bromberger J et al. Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause 2003;10(1):19–28.
12. Woods NF, Mitchell ES. Sleep symptoms during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Sleep 2010;33(4):539–49.
13. Bromberger JT, Meyer PM, Kravitz HM et al. Psychologic distress and natural menopause: a multiethnic community study. Am J Pub Health 2001;91(9):1435–42.
14. Avis NE, Brambilla D, McKinlay SM et al. A longitudinal analysis of the association between menopause and depression. Results from the Massachusetts Women's Health Study. Ann Epidemiol 1994;4(3):214–20.
15. Juang KD, Wang SJ, Lu SR et al. Hot flashes are associated with psychological symptoms of anxiety and depression in peri- and post- but not premenopausal women. Maturitas 2005;52(2):119–26.
16. Freedman RR, Roehrs TA. Sleep disturbance in menopause. Menopause 2007;14(5):826–29.
17. Woods NF, Mitchell ES, Adams C. Memory functioning among midlife women: observations from the Seattle Midlife Women's Health Study. Menopause 2000;7(4):257–65.
18. Weber MT, Maki PM, McDermott MP. Cognition and mood in perimenopause: a systematic review and meta-analysis. J Steroid Biochem Mol Biol 2014;142:90–98.
19. Pastore LM, Carter RA, Hulka BS et al. Self-reported urogenital symptoms in postmenopausal women: Women's Health Initiative. Maturitas 2004;49(4):292–303.
20. Santoro N, Komi J. Prevalence and impact of vaginal symptoms among postmenopausal women. J Sex Med 2009;6(8):2133–42.
21. Avis NE, Stellato R, Crawford S et al. Is there an association between menopause status and sexual functioning? Menopause 2000;7(5):297–309.
22. Sampselle CM, Harlow SD, Skurnick J et al. Urinary incontinence predictors and life impact in ethnically diverse perimenopausal women. Obstet Gynecol 2002;100(6):1230–38.
23. Szoeke CE, Cicuttini FM, Guthrie JR et al. The relationship of reports of aches and joint pains to the menopausal transition: a longitudinal study. Climacteric 2008;11(1):55–62.
24. Barnabei VM, Cochrane BB, Aragaki AK et al. Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative. Obstet Gynecol 2005;105(5 Pt 1):1063–73.
25. Chlebowski RT, Cirillo DJ, Eaton CB et al. Estrogen alone and joint symptoms in the Women's Health Initiative randomized trial. Menopause 2013;20(6):600–8.
26. Brown LM, Clegg DJ. Central effects of estradiol in the regulation of food intake, body weight, and adiposity. J Steroid Biochem Mol Biol 2010;122(1-3):65–73.
27. Davis SR, Castelo-Branco C, Chedraui P et al. Understanding weight gain at menopause. Climacteric 2012;15(5):419–29.
28. Grady D. Clinical practice. Management of menopausal symptoms. N Engl J Med 2006;355(22):2338–47.
29. Soares CN, Almeida OP, Joffe H et al. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 2001;58(6):529–34.
30. Morrison MF, Kallan MJ, Ten Have T et al. Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial. Biol Psychiatry 2004;55(4):406–12.
31. Maki PM, Sundermann E. Hormone therapy and cognitive function. Hum Reprod Update 2009;15(6):667–81.
32. Beck KL, Anderson MC, Kirk JK. Transdermal estrogens in the changing landscape of hormone replacement therapy. Postgrad Med 2017:1–5.
33. Nedrow A, Miller J, Walker M et al. Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review. Arch Intern Med 2006;166(14):1453–65.
34. Bhavnani BR, Stanczyk FZ. Misconception and concerns about bioidentical hormones used for custom-compounded hormone therapy. J Clin Endocrinol Metab 2012;97(3):756–59.
35. Santen RJ, Allred DC, Ardoin SP et al. Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab 2010;95(7 Suppl 1):s1–s66.
36. Shamliyan TA, Kane RL, Wyman J et al. Systematic review: randomized, controlled trials of nonsurgical treatments for urinary incontinence in women. Ann Intern Med 2008;148(6):459–73.
37. Appa AA, Creasman J, Brown JS et al. The impact of multimorbidity on sexual function in middle-aged and older women: beyond the single disease perspective. J Sex Med 2014;11(11):2744–55.
38. Wierman ME, Arlt W, Basson R et al. Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2014;99(10):3489–510.
39. Mitchell ES, Woods NF. Symptom experiences of midlife women: observations from the Seattle Midlife Women's Health Study. Maturitas 1996;25(1):1–10.
40. Sowers MR, Zheng H, Jannausch ML et al. Amount of bone loss in relation to time around the final menstrual period and follicle-stimulating hormone staging of the transmenopause. J Clin Endocrinol Metab 2010;95(5):2155–62.
41. Kannel WB, Hjortland MC, McNamara PM et al. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med 1976;85(4):447–52.
42. Rossouw JE, Prentice RL, Manson JE et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007;297(13):1465–77.
43. Marjoribanks J, Farquhar C, Roberts H et al. Long-term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev 2017 Jan 17;1:CD004143. doi: 10.1002/14651858.CD004143.pub5
19 July 2017
Practice
FIRST TIME: The first time you face your bias to those ‘other’ therapies
1. Murad MH, Asi N, Mouaz Alsawas M et al. New evidence pyramid. Evidence-Based Med 2016;21:125–27. Available online at http://ebm.bmj.com/content/21/4/125
2. Strathern P. Quacks, rogues and charlatans. London: The Royal College of Physicians, 2017. Available online at https://shop.rcplondon.ac.uk/products/quacks-rogues-and-charlatans?variant=11415214789
3. Therapeutics Education Collaboration. Best Science (BS) medicine podcast. Available online at https://therapeuticseducation.org/bs-medicine-podcast
4. US Food and Drug Administration. Table of pharmacogenomic biomarkers in drug labeling. Available online at https://www.fda.gov/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm083378.htm
5. National Human Genome Research Institute. All about The Human Genome Project (HGP). Available online at https://www.genome.gov/10001772/all-about-the--human-genome-project-hgp/
MEDICOLEGAL: The financial sting in the tail of defence
1. Winefield 83Pharm06/30P
2. Winefield v Professional Conduct Committee (High Court Wellington, CIV–2006-485-2225).
3. Heron 768Med 15317P
MENTAL HEALTH: Porn is acknowledged as having the potential for addiction
1. Weir K. Is pornography addictive? Monitor on Psychology 2014 Apr;45(4):46. Available online at http://bit.ly/1BuijA9
SPORTS MEDICINE: Athletes’ oral health often does not get a second thought
1. Needleman I, Ashley P, Fine P et al. Oral health and elite sport performance. Br J Sports Med 2015; 49:3–6.
5 July 2017
Practice
CHILD HEALTH: Rotavirus vaccination has reduced gastroenteritis in infants
1. Galloway Y, Jack S, Hewitt J. Rotavirus in New Zealand, 2015. Wellington: Institute of Environmental Science and Research Limited, 22 December 2016.
2. Macartney KK, Porwal M, Dalton D et al. Decline in rotavirus hospitalisations following introduction of Australia’s national rotavirus immunisation programme. J Paediatr Child Health 2011;47(5):266–70.
3. Rosie B, Dalziel S, Wilson E et al. Epidemiology of intussusception in New Zealand pre-rotavirus vaccination. N Z Med J 2016;129(1442):36–45.
4. Hawken S, Ducharme R, Rosella LC et al. Assessing the risk of intussusception and rotavirus vaccine safety in Canada. Hum Vaccin Immunother 2017;13(3):703–10.
5. Markkula J, Hemming-Harlo M, Salminen MT et al. Rotavirus epidemiology 5–6 years after universal rotavirus vaccination: persistent rotavirus activity in older children and elderly. Infect Dis (Lond) 2017;49(5):388–95.
ELDER HEALTH: Non-medical bits of being old: housing, income, community, attachment
1. Russell C, B Hill, Basser M. Older people’s lives in the inner city: hazardous or rewarding? Aust N Z J Public Health 1998;22(1):98–106.
2. Keall MD, Pierse N, Howden-Chapman P et al. Home modifications to reduce injuries from falls in the home injury prevention intervention (HIPI) study: a cluster-randomised controlled trial. Lancet 2015;385(9964):231–38.
3. Keall MD, Pierse N, Howden-Chapman P et al. Cost-benefit analysis of fall injuries prevented by a programme of home modifications: a cluster randomised controlled trial. Injury Prev 2017;23(1):22–26.
4. Bennett J, Howden-Chapman P, Chisholm E et al. Towards an agreed quality standard for rental housing: field testing of a New Zealand housing WOF tool. Aust N Z J Public Health 2016;40(5):405–11.
5. Gillespie-Bennett J, Keall M, Howden-Chapman P et al. Improving health, safety and energy efficiency in New Zealand through measuring and applying basic housing standards. N Z Med J 2013;126(1379):74–85.
6. O’Sullivan KC, Howden-Chapman PL, Stanley J et al. Kids in the cold: outcomes for New Zealand households with children using prepayment metering for electricity. N Z Med J 2013;126(1371):71–81.
7. Pierse N, Carter K, Bierre S et al. Examining the role of tenure, household crowding and housing affordability on psychological distress, using longitudinal data. J Epidemiol Commun Health 2016;70(10):961–66.
8. Wiles JL, Rolleston A, Pillai A et al. Attachment to place in advanced age: A study of the LiLACS NZ cohort (2017). Soc Sci Med 2017;185:27–37.
HOW TO TREAT: Gout
1. Khanna D, Fitzgerald JD, Khanna PP et al. American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken) 2012;64(10):1431–46.
2. Khanna D, Khanna PP, Fitzgerald JD et al. 2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res (Hoboken) 2012;64(10):1447–61.
3. Zhang W. EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT). Ann Rheum Dis 2006;65(10):1301–11.
4. Zhang W, Doherty M, Bardin T et al. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006;65(10):1312–24.
5. Graf SW, Whittle SL, Wechalekar MD et al. Australian and New Zealand recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion in the 3e Initiative. Int J Rheum Dis 2015;18(3):341–51.
6. Jordan KM, Cameron JS, Snaith M et al. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout. Rheumatology (Oxford) 2007:46(8);1372–74.
7. Winnard D, Wright C, Taylor WJ et al. National prevalence of gout derived from administrative health data in Aotearoa New Zealand. Rheumatology (Oxford) 2012;51(5):901–09.
8. Terkeltaub RA, Furst DE, Bennett K et al. High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study. Arthritis Rheum 2010;62(4):1060–68.
9. Waitemata District Health Board. Colchicine – safe prescribing – toe the line! 2015. Available online at www.saferx.co.nz/colchicine.pdf
10. Daoussis D, Antonopoulos I, Yiannopoulos G et al. ACTH as first line treatment for acute gout in 181 hospitalized patients. Joint Bone Spine 2013;80(3):291–94.
11. Man CY, Cheung ITF, Cameron PA et al. Comparison of oral prednisolone/paracetamol and oral idomethacin/paracetamol combination therapy in the treatment of acute goutlike arthritis: a double-blind, randomized, controlled trial. Ann Emerg Med 2007;49(5):670–77.
12. Nasser-Ghodsi N, Harrold LR. Overcoming adherence issues and other barriers to optimal care in gout. Curr Opin Rheumatol 2015;27(2):134–38.
13. Stamp LK, Taylor WJ, Jones PB et al. Starting dose is a risk factor for allopurinol hypersensitivity syndrome: A proposed safe starting dose of allopurinol. Arthritis Rheum 2012;64(8):2529–36.
14. Taylor TH, Mecchella JN, Larson RJ et al. Initiation of allopurinol at first medical contact for acute attacks of gout: a randomized clinical trial. Am J Med 2012;125(11):1126–27.
15. Hill, EM, Sky K, Sit M et al. Does starting allopurinol prolong acute treated gout? A randomized clinical trial. J Clin Rheum 2015;21(3):120–25.
16. Nasser-Ghodsi N, Harrold LR. Overcoming adherence issues and other barriers to optimal care in gout. Curr Opin Rheum 2015;27(2):134–38.
17. Dalbeth N, Winnard D, Gow PJ et al. Urate testing in gout: why, when and how. N Z Med J 2015;128(1420):65–68.
18. Pharmac. Out with gout. Available online at www.pharmac.health.nz/medicines/your-health/gout
19. Kumar S, Gow P. A survey of indications, results and complications of surgery for tophaceous gout. N Z Med J 2002;115(1158):U109.
21 June 2017
Practice
CHILD HEALTH: Infant feeding and food allergy – the current state of play
1. du Toit G, Tsakok T, Lack S et al. Prevention of food allergy. J Allergy Clin Immunol 2016;137(4):998–1010.
2. American Academy of Pediatrics Committee on Nutrition. Hypoallergenic infant formulas. Pediatrics 2000;106(2 Pt 1):346–49.
3. Koplin JJ, Dharmage SC, Ponsonby AL et al. Environmental and demographic risk factors for egg allergy in a population-based study of infants. Allergy 2012;67(11):1415¬–22.
4. Boyle RJ, Ierodiakonou D, Khan T et al. Hydrolysed formula and risk of allergic or autoimmune disease: systematic review and meta-analysis. BMJ 2016;352:i974.
5. Koplin JJ, Osborne NJ, Wake M et al. Can early introduction of egg prevent egg allergy in infants? A population-based study. J Allergy Clin Immunol 2010 Oct;126(4):807–13.
6. Du Toit G, Katz Y, Sasieni P et al. Early consumption of peanuts in infancy is associated with a low prevalence of peanut allergy. J Allergy Clin Immunol 2008;122(5):984–91.
7. Du Toit G, Roberts G, Sayre PH et al. Randomized trial of peanut consumption in infants at risk for peanut allergy. NEJM 2015;372(9):803–13.
8. Perkin MR, Logan K, Tseng A et al. Randomized trial of introduction of allergenic foods in breast-fed infants. NEJM 2016;374:1733–43.
9. Palmer DJ, Metcalfe J, Makrides M et al. Early regular egg exposure in infants with eczema: a randomized controlled trial. J Allergy Clin Immunol 2013;132(2):387–92 e1.
10. Natsume O, Kabashima S, Nakazato J et al. Two-step egg introduction for prevention of egg allergy in high-risk infants with eczema (PETIT): a randomised, double-blind, placebo-controlled trial. Lancet 2017;389(10066):276–86.
11. Grimshaw KE, Maskell J, Oliver EM et al. Diet and food allergy development during infancy: birth cohort study findings using prospective food diary data. J Allergy Clin Immunol 2014;133(2):511–19.
12. Ellwood P, Asher MI, Garcia-Marcos L et al. Do fast foods cause asthma, rhinoconjunctivitis and eczema? Global findings from the International Study of Asthma and Allergies in Childhood (ISAAC) phase three. Thorax 2013;68(4):351–60.
FIRST TIME: The first time you encounter an immunisation denier
1. Sheth JN, Frazier GL. A model of strategy mix choice for planned social change. J Marketing 1982;46(1):15–26. Available online at http://bit.ly/2rG19mQ
MEDICOLEGAL: Threats of harm: When doctors must think like lawyers
1. Privacy Commissioner. Health Information Privacy Code 1994. Rule 11(2)(f).
2. Office of the Privacy Commissioner. Case Note 279251 [2017] NZ PrivCmr 4 – Police were right to disclose mental health information.
SPORTS MEDICINE: FAI syndrome – A problem for the young and the hip
1. Griffin DR, Dickenson EJ, O’Donnell J et al. The Warwick Agreement on femoroacetabular impingement syndrome (FAI syndrome): an international consensus statement. Br J Sports Med 2016 (50) 1169–76.
7 June 2017
Practice
CHILD HEALTH: With varicella vaccine in the NIS, will chickenpox become rare?
1. Ministry of Health. Immunisation Handbook 2014. 3rd edition, 2016. Wellington: Ministry of Health, 2016. Available online from: http://www.health.govt.nz/publication/immunisation-handbook-2014-3rd-edn
2. Immunisation Advisory Centre. Antigen Review for the New Zealand National Immunisation Schedule, 2016: Varicella-zoster virus (chickenpox). Auckland: Immunisation Advisory Centre, 2016. Available online from: http://www.immune.org.nz/sites/default/files/research_articles/Acdm%20Rev%202016%20Varicella_finaledit2.pdf
3. Wen SC, Miles F, McSharry B et al. Varicella in a paediatric intensive care unit: 10-year review from Starship Children's Hospital, New Zealand. J Paediatr Child Health 2014;50(4):280–85.
4. Wen SC, Best E, Walls T et al. Prospective surveillance of hospitalisations associated with varicella in New Zealand children. J Paediatr Child Health 2015;51(11):1078–83.
5. World Health Organization. Safety of varicella and MMRV vaccines: A systematic review (2013). Available online from: http://www.who.int/immunization/sage/meetings/2014/april/3_Safety_of_varicella_and_MMRV_vaccines_A_systematic_review.pdf?ua=1
6. Pharmac. Changes to the National Immunisation Schedule, 28 July 2016. Available online from https://www.pharmac.govt.nz/news/notification-2016-07-28-immunisation-schedule/
HEARTBEAT: Adverse statin effects overstated by epidemiology-based studies
1. Jones M, Tett S, Peeters GMEE et al. New-onset diabetes after statin exposure in elderly women: The Australian Longitudinal Study on Women’s Health. Drugs Aging (2017) 34:203–9.
2. Hulley S, Grady D, Bush T et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998 Aug 19;280(7):605–13.
3. Cholesterol Treatment Trialists’ (CTT) Collaboration. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials. Lancet 2015;385:1397–405.
4. Cholesterol Treatment Trialists’ (CTT) Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials. Lancet 2010;376:1670–81.
5. Sattar N, Preiss D, Murray HM et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet 2010;375:735–42.
24 May 2017
Practice
FROM THE LAB: Variant haemoglobins seen more often with rise in HbA1c testing
1. Silva JF, Pimental AL, Camargo JL. Effect of iron deficiency anaemia on HbA1c levels is dependent on the degree of anaemia. Clin Biochem 2016;49:117–20.
2. Vos FE, Schollum JB, Coulter CV et al. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring. Nephrology (Carlton) 2012;17:182–88.
3. Cavagnolli G, Pimentel AL, Freitas PA et al. Factors affecting A1C in non-diabetic individuals: Review and meta-analysis. Clin Chim Acta 2015 445:107–14.
MEDICOLEGAL: Rules vs caring doctor: The dilemma, whether to be a test case?
1. A: Barrister and Solicitor v New Zealand Law Practitioners Disciplinary Tribunal, High Court Auckland AP 59/SW01, 19 December 2001.
2. O v Professional Conduct Committee, CIV 2010-404-37, High Court Auckland, 5 August 2011.
MENTAL HEALTH: Patients and medical staff find the usefulness of mindfulness
1. Lau MA, McMain SF. Integrating mindfulness meditation with cognitive and behavioural therapies: The challenge of combining acceptance- and change-based strategies. Can J Psychiatry 2005;50(13):863–69.
2. Davidson RJ, Kaszniak AW. Conceptual and methodological issues in research on mindfulness and meditation. Am Psychologist 2015;70(7):581–92.
3. Crane RS, Brewer J, Feldman C et al. What defines mindfulness-based programs? The warp and the weft. Psychol Med 2017;47(6):990–99.
4. Kabat-Zinn J. Full catastrophe living: Using the wisdom of your body and mind to face stress, pain and illness. New York: Dell, 1990, p442.
5. Van der Velden AM, Kuyken W, Wattar U et al. A systematic review of mechanisms of change in mindfulness-based cognitive therapy in the treatment of recurrent major depressive disorder. Clin Psychology Rev 2015;37:26–39.
6. Zeidan F, Martucci KT, McHaffie JG et al. Brain mechanisms supporting the modulation of pain by mindfulness meditation. J Neurosci 2011;31(14):5540–48.
7. Hilton L, Hempel S, Ewing BA et al. Mindfulness meditation for chronic pain: Systematic review and meta-analysis. Ann Behav Med 2017;51(2):199–213.
10 May 2017
Practice
CHILD HEALTH: National Immunisation Schedule changes to be made by mid-2017
1. Pharmac. Changes to the National Immunisation Schedule, 28 July 2016. Avialable online at https://www.pharmac.govt.nz/news/notification-2016-07-28-immunisation-schedule/
2. Dobson SR, McNeil S, Dionne M et al. Immunogenicity of two doses of HPV vaccine in younger adolescents vs three doses in young women: a randomized clinical trial. JAMA 2013;309(17):1793–802.
3. American Academy of Pediatrics Committee on Infectious Diseases. Prevention of varicella: Recommendations for use of varicella vaccines in children, including a recommendation for a routine two-dose varicella immunisation schedule. Pediatrics 2007;120;221–31.
ELDER HEALTH: Staying strong and independent the way to ‘sell’ falls prevention
1. Jones S, Blake S, Hamblin R et al. Reducing harm from falls. NZMJ 2016;129:1446.
HEARTBEAT: Statin intolerance is poorly understood, as is this patient group
1. Efficacy and tolerability of evolocumab vs ezetimibe in patients with muscle-related statin intolerance: The GAUSS-3 randomized clinical trial. JAMA 2016;315(5):1580–90.
26 April 2017
Practice
MEDICOLEGAL: ‘Life repeats lessons not learned’: Five tips to avoid complaints
1. Hilfiker D. Facing our mistakes. N Engl J Med 1984; 310:118–122. Available online at http://www.davidhilfiker.com/index.php?option=com_content&view=article&id=51:facing-our-mistakes&Itemid=41
2. Localio AR, Lawthers AG, Brennan TA et al. Relationship between malpractice claims and adverse incidents due to negligence: results of Harvard Medical Practice Study III. N Engl J Med 1991;325:245–51.
3. Studdert DM, Mello MM, Gawande AA et al. Claims, errors and compensation payments in medical malpractice litigation. N Engl J Med 2006;354:2024–33.
4. Cunningham W, Crump R, Tomlin A. The characteristics of doctors receiving medical complaints: a cross sectional survey of doctors in New Zealand. NZMJ 2003;116:1183.
5. Office of the HDC. Complaints to the Health and Disability Commissioner involving doctors 1 January 2009 to 31 December 2015. Available online at http://www.hdc.org.nz/publications/other-publications-from-hdc/other-reports/complaints-to-health-and-disability-commissioner-involving-doctors
6. Nasca RJ, Whitehurst LA, Andrew LB, et al (eds). Medical malpractice: How to prevent and survive a suit. Brooklandville (MD): Data Trace Publishing Company. Available online at https://www.datatrace.com/medical-malpractice-how-to-prevent-and-survive-a-suit.html
7. Surgeons’ tone of voice: a clue to malpractice history. Surgery 2002;132(1):1–9.
8. Dugdale DC, Epstein R, Pantilat SZ. Time and the patient–physician relationship. J Gen Intern Med 1999 Jan 14;Suppl 1:S34-S40.
MENTAL HEALTH: Natural disaster has a significant psychological impact
1. Fergusson DM, Horwood LJ, Boden JM et al. Impact of a major disaster on the mental health of a well-studied cohort. JAMA Psychiatry 2014 Sep 1;71(9):1025–31.
2. Beaglehole B, Bell C, Frampton C et al. The impact of the Canterbury earthquakes on prescribing for mental health. Aust N Z J Psychiatry 2015 Aug 1;49(8):742–50.
3. Ministry of Health. Framework for psychosocial support in emergencies. Wellington: Ministry of Health, 2016.
4. Post-traumatic stress disorder: management. NICE Clinical Guideline [CG26]. Available online at https://www.nice.org.uk/Guidance/cg26
5. Johal S, Mounsey Z, Tuohy R et al. Coping with disaster: general practitioners’ perspectives on the impact of the Canterbury earthquakes. PLoS Currents Disasters 2014 Apr;2.
12 April 2017
Practice
VACCINES: The new national standards underpin the vaccine cold chain
1. Ministry of Health. National Standards for Vaccine Storage and Transportation for Immunisation Providers. Wellington: Ministry of Health, February 2017.
2. Ministry of Health. Cold Chain Accreditation Provider Self-Assessment Form. Wellington: Ministry of Health, March 2017.
3. Ministry of Health. Cold Chain Accreditation Provider Review Form. Wellington: Ministry of Health March 2017.
4. Ministry of Health. Cold Chain Management Policy Template. Wellington: Ministry of Health March 2017.
HEARTBEAT: Mechanical aortic valve recipient wants a switch to dabigatran
1. Connolly SJ, Ezekowitz MD, Yusuf S et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009 Sep 17;361(12):1139–51.
2. Eikelboom JW, Connolly SJ, Brueckmann M et al. Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med 2013 Sep 26;369(13):1206–14.
29 March 2017
Practice
CHILD HEALTH: Evidence supports ventrogluteal IM route in children, young people
1. Wynaden D, Landsborough I, McGowan S et al. Best practice guidelines for the administration of intramuscular injections in the mental health setting. Int J Ment Health Nurs 2006;15:195–200.
2. Covington TP, Trattler MR. Bull’s eye! Finding the right target for IM injections. Nursing 1997;27:62–63.
3. Donaldson C, Green J. Using the ventrogluteal site for intramuscular injections. Nursing Times 2005;101(16):36–38.
4. Chan VO, Colville J, Persaud T et al. Intramuscular injections into the buttocks: are they truly intramuscular? Eur J Radiol 2006;58;480–84.
5. Rodger MA, King L. Drawing up and administering intramuscular injections: a review of the literature. J Adv Nursing 2000;31(3):574–82.
6. Small SP. Preventing sciatic nerve injury from intramuscular injections: literature review. J Adv Nursing 2003;47(3):287–96.
7. Beecroft PC, Redick SA. Intramuscular injection practices of paediatric nurses: site selection. Nurse Educator 1990;15:23–28.
8. Wong D. Ventrogluteal site for intramuscular injections. Wong on Web (2006). Available online at www.mosbysdrugconsult.com/WOW/fyi04.html
9. Shaw A. Choosing the right injection site. Kai Tiaki Nursing N Z December/January 2002/2003.
10. Burbridge BE. Computed tomographic measurement of gluteal subcutaneous fat thickness in reference to failure of gluteal intramuscular injections. J Appl Commun Res 2007;58(2):72–75.
11. Greenway K. Using the ventrogluteal site for intramuscular injections. Nursing Standard 2004;18(25):39–42.
12. Greenway K, Merriman C, Statham D. Using the ventrogluteal site for intramuscular injections. Learn Disab Pract 2006;9(8).
13. Scott W, Marfell-Jones M. Evidence alone is not enough to bring about practice change. Kai Tiaki Nursing N Z February 2004
FROM THE LAB: Non-melanoma skin cancer - A risk and management update
1. Werner RN, Sammain A, Erdmann R et al. The natural history of actinic keratosis: a systematic review. Br J Dermatol 2013; 69:502–18.
2. Cancer Council Australia. Clinical Practice Guide. Basal cell carcinoma, squamous cell carcinoma (and related lesions) – a guide to clinical management in Australia. November 2008, Cancer Council Australia.
3. McKenzie CA, Chen AC, Choy B et al. Classification of high risk basal cell carcinoma subtypes: experience of the ONTRAC study with proposed definitions and guidelines for pathological reporting. Pathology 2016 Aug;48(5):395–97.
MEDICOLEGAL: 'Life repeats lessons not learned' - consider this for all complaints
1. The Health and Disability Commissioner. Complaints to the Health and Disability Commissioner involving doctors: analysis and report 2009–2015. 1 January 2009 to 31 December 2015. Office of the HDC, 2016. Available online at http://www.hdc.org.nz/publications/other-publications-from-hdc/other-reports/complaints-to-health-and-disability-commissioner-involving-doctors
2. Cunningham W. The immediate and long-term impact on New Zealand doctors who receive patient complaints. N Z Med J 2004 Jul 23;117(1198):U972.
SPORTS MEDICINE: Evidence finds exercise affects risk and recovery from cancer
1. Galvão DA, Newton RU. Review of exercise intervention studies in cancer patients. J Clin Oncol 2005 Feb 1;23(4):899–909.
2. Galvão DA, Taaffe DR, Spry N et al. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. J Clin Oncol 2010 Jan 10;28(2):340–47.
3. Courneya KS, Segal RJ, Mackey JR et al. Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol 2007 Oct 1;25(28):4396–404.
4. Friedenreich CM, Neilson HK, Farris MS et al. Physical activity and cancer outcomes: a precision medicine approach [Review]. Clin Cancer Res 2016 Oct 1;22(19):4766–75.
5. Gunnell AS, Joyce S, Tomlin S et al. Physical activity and survival among long-term cancer survivor and non-cancer cohorts. Front Public Health 2017;5:19. Available online at http://journal.frontiersin.org/article/10.3389/fpubh.2017.00019/full
6. Galvão DA, Taaffe DR, Spry N. Enhancing active surveillance of prostate cancer: the potential of exercise medicine [Review]. Nat Rev Urol 2016 May;13(5):258–65.
7. Betof AS, Lascola CD, Weitzel D et al. Modulation of murine breast tumor vascularity, hypoxia and chemotherapeutic response by exercise. J Natl Cancer Inst 2015 Mar 16;107(5). Available online at https://www.ncbi.nlm.nih.gov/pubmed/25780062
8. Pedersen L, Idorn M, Olofsson GH et al. Voluntary running suppresses tumor growth through epinephrine- and IL-6-dependent NK cell mobilization and redistribution. Cell Metab 2016 Mar 8;23(3):554–62.
9 Newton RU, Galvão DA. Accumulating evidence for physical activity and prostate cancer survival: time for a definitive trial of exercise medicine? Eur Urol 2016 Oct;70(4):586–87.
10. Courneya KS, Vardy JL, O'Callaghan CJ. Effects of a structured exercise program on physical activity and fitness in colon cancer survivors: one year feasibility results from the CHALLENGE Trial. Cancer Epidemiol Biomarkers Prev 2016 Jun;25(6):969–77.
11. Schmitz KH, Courneya KS, Matthews C et al; American College of Sports Medicine. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 2010 Jul;42(7):1409–26. Available online at https://www.ncbi.nlm.nih.gov/pubmed/20559064
12. Rock CL, Doyle C, Demark-Wahnefried W et al. Nutrition and physical activity guidelines for cancer survivors [Review]. CA Cancer J Clin 2012 Jul-Aug;62(4):243–74. Erratum in: CA Cancer J Clin 2013 May;63(3):215. https://www.ncbi.nlm.nih.gov/pubmed/22539238
CLINICAL UPDATE: Rare presentations occur quite often, rare disorders are really common
1. European Organisation for Rare Diseases. Rare diseases: understanding this public health priority. Paris: Eurordis, November 2005. Available online at www.eurordis.org/IMG/pdf/princeps_document-EN.pdf
2. Phillips WR. Zebras on the commons: rare conditions in family practice. J Am Board Fam Pract 2004;17:283–86.
3. NZORD. Patient support group survey 2015. Wellington: NZORD, 2015. www.nzord.org.nz
4. Knight AW, Senior TM. The common problem of rare disease in general practice. Med J Austr 2006;185:82–83.
15 March 2017
Practice
MENTAL HEALTH: Cost-effective option for providing mental health consultations
1. Robinson PJ, Strosahl KD. Behavioral health consultation and primary care: Lessons learned. J Clin Psychol Med Settings 2009;16:58–71.
2. Strosahl K. Training behavioural and primary care providers for integrated care. A core competencies approach. In: Behavioural integrative are treatments that working the primary care setting. Edited by O'Donohue W, Byrd M, Cummings N and Henderson D. New York: Brunner-Routledge, 2005:pp 15–52.
3. Strosahl K, Robinson P, Gustavsson T. Brief interventions for radical change: principles and practice of focussed acceptance and commitment therapy. Oakland, California: New Harbinger Publications, 2012.
4. A Tjak JG, Davis ML, Morina N, et al. A meta-analysis of the efficacy of acceptance and commitment therapy for clinically relevant mental and physical health problems. Psychother Psychosom 2015;84(1):30–6.
5. Whitebird RR, Solberg LI, Jaeckels NA, et al. Effective Implementation of collaborative care for depression: what is needed? Am J Manag Care 2014;20(9):699–707.
CLINICAL UPDATE - NUTRITION: Nutrition care for patients with cardiovascular risk factors
1. Ministry of Health. New Zealand Health Survey: Annual update of key findings 2012/13. Wellington: Ministry of Health, 2013.
2. Riserus U. Cardiovascular disease. Nutrition for the primary care provider. Bier D et al (eds). World Rev Nutr [Vol 111;94–99]. Basel: Karger, 2015.
CLINICAL UPDATE – POSTPARTUM SLEEP: Preparing expectant mothers for postpartum sleep disruption
1. Montgomery-Downs HE, Insana SP et al. Normative longitudinal maternal sleep: the first 4 postpartum months. Am J Obstet Gynecol 2010;203:465.e1–7.
2. Insana SP, Williams KB, Montgomery-Downs HE. Sleep disturbance and neurobehavioural performance among postpartum women. Sleep 2013;36(1):73–81.
3. Dawson D, Reid K. Fatigue, alcohol and performance impairment. Nature 1997;388:235–37.
4. Dennis CL, Ross L. Relationships among infant sleep patterns, maternal fatigue, and development of depressive symptomatology. Birth 2005;32:187–93.
5.Wolfson AR, Crowley S, Anwer U et al. Changes in sleep patterns and depressive symptoms in first-time mothers: last trimester to one-year postpartum. Behav Sleep Med 2003;1:54–67.
6. Wilke G, Shapiro CM. Sleep deprivation and the postnatal blues. J Psychosom Res 1992;36:309–16.
7. Filtness AJ, MacKenzie J, Armstrong K. Longitudinal change in sleep and daytime sleepiness in postpartum women. PLoS ONE 2014;9(7): e103513.doi:10.1371/journal.pone.0103513.
8. Thomas KA, Speiker S. Sleep, depression, and fatigue in late postpartum. Am J Matern Child Nurs 2016 Mar–Apr;41(2):104–9.
9. McBean A, Montgomery-Downs H. What are postpartum women doing while the rest of the world is asleep? J Sleep Res 2015;24(3):270–78.
HEARTBEAT: Delayed surgical appointments raise risk for 78-year-old with AF
1. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010;31:2369–429. Available online at http://bit.ly/2kkEHvZ
2. Keene L, Bagshaw P, Nicholls MG et al. Funding New Zealand’s public healthcare system: time for an honest appraisal and public debate. NZMJ 2016;129(1435):10–20.
1 March 2017
Practice
CHILD HEALTH: Child asthma and wheeze: An equity issue for general practice
1. Asher MI, Stewart AW, Clayton T et al. Has the prevalence and severity of symptoms of asthma changed among children in New Zealand? ISAAC phase three. NZ Med J 2008;121(1284):52–63.
2. Penders J, Kummeling I, Thijs C. Infant antibiotic use and wheeze and asthma risk: a systematic review and meta-analysis. Eur Resp J 2011;38(2):295–302.
3. Strachan D, Limb ER, Pearce N et al. Asthma mortality. The global asthma report. Auckland, New Zealand, 2014.
4. Jones B, Ingham TR, Reid S et al. He Maramatanga Huango: Asthma health literacy for Maori children in New Zealand. University of Otago, 2015.
5. Telfar Barnard L, Baker M, Pierse NJZ. The impact of respiratory disease in New Zealand: 2014 update. Wellington: The Asthma Foundation, 2015.
6. Simpson J, Oben G, Wicken A et al. Child poverty monitor: 2014 technical report. University of Otago, 2014.
7. Juniper EF, Guyatt GH, Feeny DH et al. Measuring quality of life in children with asthma. Qual Life Res 1996;5(1):35–46.
8. Juniper EF, Bousquet J, Abetz L et al. Identifying ‘well-controlled’and ‘not well-controlled’asthma using the Asthma Control Questionnaire. Resp Med 2006;100(4):616–21.
9. Walker N. He tapu te ha: Space to breathe. Wellington: Pharmac, 2014.
MEDICOLEGAL: Problem patient personalities – terminate or behaviour-manage?
1. Groves JE. Taking care of the hateful patient. NEJM 1978;298(16):883–87.
2. The HDC Code of Health and Disability Services Consumers’ Rights Regulation 1996. Right 10: the right to make a complaint. Available online at www.hdc.org.nz
MENTAL HEALTH: Success largely due to patient getting on with therapist
1. Norcross JC. Psychotherapy relationships that work: evidence-based responsiveness (2nd edn). New York, NY: Oxford University Press, 2011
2. Evidence-based therapy relationships (Norcross JC, ed). 2010. Available online at http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.463.7645&rep=rep1&type=pdf
3. Rousmaniere A. Scott Miller on why most therapists a just average (and how we can improve. Psychotherapy.net, 2013 [Interview]. Available online at https://www.psychotherapy.net/interview/scott-miller-interview
15 February 2017
Practice
CLINICAL UPDATE: Nutrition a cornerstone in care for people with type 2 diabetes
1. Mann J. Diabetes mellitus. In: Nutrition for the primary care provider. Bier D, et al (eds). World Rev Nutr Diet. Basel: Karger, 2015;111;110–15.
2. Diabetes New Zealand. Food and nutrition. Available online at http://www.diabetes.org.nz/food_and_nutrition
1 February 2017
Practice
FROM THE LAB: Creatinine results can show drug, diet or supplement artefacts
1. Samra M, Abcar AC. False estimates of elevated creatinine. Perm J 2012 Spring;16(2):51–52.
2. KDIGO. Clinical practice guideline for acute kidney injury. Kidney Int Suppl 2012 Mar. 2(1). Available online at http://www.kidney-international.org
3. Preiss DJ , Godber IM , Lamb EJ et al. The influence of a cooked-meat meal on estimated glomerular filtration rate. Ann Clin Biochem 2007;44:35–42.
MENTAL HEALTH: Double jeopardy – Stigma and discrimination in mental health
1. Corrigan P. How stigma interferes with mental health care. Am Psychol 2004 Oct;59(7):614–25.
2. Betton V, Borschmann R, Docherty M et al. The role of social media in reducing stigma and discrimination. Br J Psychiatry 2015 Jun 1;206(6):443–44.
3. Thornicroft A, Goulden R, Shefer G et al. Newspaper coverage of mental illness in England 2008–2011. Br J Psychiatry 2013 Apr 1;202(s55):s64–69.
2016
14 December 2016
Treat the patient, not the laboratory urine result
1. Upton A, McEwan M, Williamson D. Urinalysis requests on the elderly residing in the Auckland community: tick box requesting? N Z Med J 2016;129:64–70.
2. Han JH, Wilson A, Ely EW. Delirium in the older emergency department patient: a quiet epidemic. Emerg Med Clin North Am 2010;28:611–31.
3. US Food and Drug Administration. Press Announcement: FDA updates warnings for fluoroquinolone antibiotics. 2016. Available online at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm513183.htm
A Medical Council complaint can be a gruelling process
1. The review of processes concerning adverse medical events. Helen Cull QC, 12 March 2002
2. Caplan RA, Posner KL, Cheney FW. Effect of outcome on physician judgments of appropriateness of care. JAMA 1991;265(15):1957–60.
3. Hrôbjartsson A, Sofia A, Thomsen S et al. Observer bias in randomised clinical trials with binary outcomes: systemic review of trials with both blinded and non-blinded and non-blinded outcome assessors. BMJ 2012;344:e1119 doi: 10.1136
4. Medical Council. 15/32/322P
Double jeopardy: Stigma and discrimination in mental health
1. Corrigan P. How stigma interferes with mental health care. Am Psychol 2004 Oct;59(7):614–25.
2. Betton V, Borschmann R, Docherty M et al. The role of social media in reducing stigma and discrimination. Br J Psychiatry 2015 Jun 1;206(6):443–44.
3. Thornicroft A, Goulden R, Shefer G et al. Newspaper coverage of mental illness in England 2008–2011. Br J Psychiatry 2013 Apr 1;202(s55):s64–69.
23 November 2016
OCCUPATIONAL HEALTH
1. Lee L, Weston W. The aging physician. Canadian Family Physician 2012;58:17–18.
2. Durning SJ, Artino AR, Holmboe E, et al. Aging and cognitive performance: challenges and implications for physicians practicing in the 21st century. J Contin Educ Health Prof 2010;30(3):153–160. 3. Peisah C, Wilhelm K. Physician don’t heal thyself: a descriptive study of impaired older doctors. Int Psychogeriatr 2007;19(5):974–84
NUTRITION
1. Katz D. We know what a healthy diet is. Now can we stop arguing about it? www.bigthink.com/videos/david-katz-on-what-we-know-about-diet
2. Chisholm D. Diets on trial. North & South, February 2016.
3. University of Otago and Ministry of Health. A Focus on Nutrition: Key findings of the 2008/09 New Zealand Adult Nutrition Survey. Wellington: Ministry of Health; 2011.
HEARTBEAT
1. Guidelines for the management of atrial fibrillation. Eur Heart J 2010;31:2369–429. Available online at http://eurheartj.oxfordjournals.org/content/31/19/2369
2. Corrigendum to: “Guidelines: 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation” [Eur Heart J (2012) 33(21):2719–47; doi:10.1093/eurheartj/ehs253] Eur Heart J Sep 2013;34(36):2850–51. DOI: 10.1093/eurheartj/eht291, Table 3. Available online at http://eurheartj.oxfordjournals.org/content/34/36/2850
9 November 2016
Practice
MENTAL HEALTH: Making sense of mood swings: Not all swings are bipolar
1. Ghaemi SN, Sachs GS, Chiou AM et al. Is bipolar disorder still underdiagnosed? Are antidepressants overutilized? J Affect Disord 1999;52:135–44.
2. Ghaemi SN, Boiman EE, Goodwin FK. Diagnosing bipolar disorder and the effect of antidepressants: a naturalistic study. J Clin Psychiatry 2000;61:804–08.
3. Hirschfeld RM. Bipolar spectrum disorder: improving its recognition and diagnosis. J Clin Psychiatry 2001;62 Suppl 14:5–9.
4. Benazzi F. Bipolar II disorder is common among depressed outpatients. Psychiatry Clin Neurosci 1999;53:607–09.
5. Wehr TA, Goodwin FK. Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry 1987;144:1403–11.
NUTRITION: Nutrition care in general practice relies on opportunistic moments
1. Ministry of Health. Clinical guidelines for weight management in New Zealand adults. Wellington: Ministry of Health, 2009.
2. New Zealand Guidelines Group. New Zealand Primary Care Handbook. New Zealand Guidelines Group, 2012.
3. Ball L, Desbrow B, Leveritt, M. An exploration of individuals' preferences for nutrition care from Australian primary care professionals. Aust J Prim Health 2014;20(1):113–20.
4. Ball L, Hughes R, Desbrow B et al. Patients’ perceptions of nutrition care provided by general practitioners: focus on type 2 diabetes. Fam Pract 2012; 29(6): 719–25.
5. Loureiro M, Nayga R et al. Physician’s advice affects adoption of desirable dietary behaviours. Rev Agric Econ 2007;29(2):318–30.
6. Crowley J, Ball L, McGill A-T et al. New Zealand general practitioners’ views on providing nutrition care to patients with chronic disease: a focus group study. J Prim Health Care (In press).
7. Oldroyd J, Proudfoot J, Infante F et al. Providing healthcare for people with chronic illness: the views of Australian GPs. Med J Austr 2003;179:30–33.
8. Maryon-Davis A. Weight management in primary care: how can it be made more effective? Proc Nutr Soc 2005;64:97–103.
9. Howatson A, Wall C, Turner-Benny P. The contribution of dietitians to the primary health care workforce. J Prim Health Care 2015;7(4):324–32.
10. Australian Government. Enhanced primary care initiative. Canberra: Australian Institute of Health and Welfare, 2006.
11. Wells K, Lewis C, Leake B et al. Do physicians preach what they practice? A study of physicians’ health habits and counseling practices. J Am Med Assoc 1984;252(20):2846–48.
12. Fraser S, Leveritt M, Ball L. Patients’ perceptions of their general practitioner’s health and weight influences their perceptions of nutrition and exercise advice received. J Prim Health Care 2013;5(4):302–07.
13. Pryke R, Hughes C, Thompson S et al. Introductory Certificate in Obesity, Malnutrition and Health Workbook. Royal College of General Practitioners, United Kingdom.
14. Prochaska J, DiClemente C. Transtheoretical therapy: toward a more integrative model of change. Psych Theory Res Pract 1982;19(3):276–88.
15. Cass S, Ball L, Leveritt M. Australian practice nurses’ perceptions of their role and competency to provide nutrition care to patients living with chronic disease. Aust J Prim Health 2014;20:203–08.
Newsletters
Like it or not, we definitely live in an age of health funds rationing - NZRGPN
1. Medical Council of New Zealand annual workforce survey 2013–14
2. NZRGPN
Feature
Disjointed: Medical cannabis
1. JAMA (Whiting P, Wolff R, Deshpande S et al. 2015;313(24):2456-2473)
2. Cochrane Library (Smith L, Azariah R, Lavender VTC et al. 2015; 12 November online
3. (Wilkins C, Jawalkar P, Parker K. Recent trends in illegal drug use in New Zealand, 2006-2012: findings from the 2006, 2007, 2008, 2009, 2010, 2011 and 2012 Illicit Drug Monitoring System (IDMS). 2013.Available from: www.whariki.ac.nz/massey/learning/departments/centres-research/shore/projects/illicit-drug-monitoring-system.cfm
4. (Roxburgh A, Bruno R, Larance B, et al. Prescription of opioid analgesics and related harms in Australia. Med J Aust 2011;195:280–4).
28 September 2016
Stressful event results in transient ‘octopus pot’ apical ballooning
Templin C, Ghadri JR, Diekmann J, et al. Clinical features and outcomes of takotsubo (stress) cardiomyopathy. New Engl J Med 2015;373:929–38.
Wind turbines generate more than just electricity for the national grid
Guski R. Personal and social variables as co-determinants of noise annoyance. Noise Health1999;1(3):45–56.
Better antibodies with Prevenar 13, wider cover with Pneumovax 23
* Borman A, Heffernan H. Invasive pneumococcal disease quarterly report April–June 2016. https://surv.esr.cri.nz/PDF_surveillance/IPD/2016/2016Q2_IPDReport.pdf
* Douglas RM, Hansman D, Miles HB, et al. Pneumococcal carriage and type-specific antibody: Failure of a 14-valent vaccine to reduce carriage in healthy children. Am J Dis Child 1986;140(11):1183–85.
* Feldman C, Anderson R. Review: Current and new generation pneumococcal vaccines. J Infect 2014;69(4):309–25.
* Greenberg RN, Gurtman A, Frenck RW, et al. Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults 60-64 years of age. Vaccine 2014;32(20):2364–74.
* Institute of Environmental Science and Research Ltd (ESR). Invasive pneumococcal disease in New Zealand, 2014. Porirua: Institute of Environmental Science and Research Ltd; 2016.
* Jackson LA, Gurtman A, Rice K, et al. Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine. Vaccine 2013;31(35):3585–93.
* Jackson LA, Gurtman A, van Cleeff M, et al. Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older. Vaccine 2013;31(35):3594–602.
* Jackson LA, Gurtman A, van Cleeff M, et al. Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults. Vaccine 2013;31(35):3577–84.
* Palmu AA, Jokinen J, Nieminen H, et al. Effect of pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) on outpatient antimicrobial purchases: A double-blind, cluster randomised phase 3-4 trial. Lancet Infect Dis 2014;14(3):205–12.
* Plosker GL. 10-Valent pneumococcal non-typeable haemophilus influenzae protein D-conjugate vaccine: a review in infants and children. Paediatr Drugs 2014 Oct;16(5):425–44.
* Plosker GL. 13-valent pneumococcal conjugate vaccine: a review of its use in infants, children, and adolescents. Paediatr Drugs 2013 Oct;15(5):403–23.
* Plosker GL. 13-Valent pneumococcal conjugate vaccine: A review of its use in adults. Drugs 2015 Sep;75(13):1535–46.
* Shea KM, Weycker D, Stevenson AE, et al. Modeling the decline in pneumococcal acute otitis media following the introduction of pneumococcal conjugate vaccines in the US. Vaccine 2011;29(45):8042–48.
* Steens A, Vestrheim DF, Aaberge IS, et al. A review of the evidence to inform pneumococcal vaccine recommendations for risk groups aged 2 years and older. Epidemiol Infect 2014 Dec;142(12):2471–82.
* Tregnaghi MW, Saez-Llorens X, Lopez P, et al. Efficacy of pneumococcal nontypable haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: A double-blind randomized controlled trial. [Erratum appears in PLoS Med 2015 Jun;12(6):e1001850; PMID: 26115379]. PLoS Med 2014;11(6):e1001657.
14 September 2016
Practice
Don’t plan it, do it: Bridging the ‘knowing–doing’ gap
1. Pfeffer J, Sutton RI. The Knowing Doing Gap. Harvard Business School Press 2000. www.wenell.se/wp-content/uploads/2014/01/thinking_knowing.pdf
Is my excised lesion a dysplastic naevus, a melanoma?
1. Hocker TL, Alikhan A, Comfere N, et al. Favorable long-term outcomes in patients with histologically dysplastic nevi that approach a specimen border. J Am Acad Dermatol 2013;68(4):545–51.
2. Arumi-Uria M, McNutt MS, Finnerty B. Grading of atypia in nevi: correlation with melanoma risk. Mod Pathol 2003;16(8):764–71.
Be neither ally nor enemy when faced with the querulent patient
1. Recently retired, Professor Paul Mullen has been the preeminent forensic psychiatrist in Australasia since moving to New Zealand from Britain in 1982. He is Professor Emeritus at Monash University, Melbourne and Visiting Professor to the Institute of Psychiatry, London. He was recently Professor of Forensic Psychiatry, Monash University and Clinical Director, Victorian Institute of Forensic Mental Health, and previously Professor of Psychological Medicine at the University of Otago (1982 –1992) and Consultant Psychiatrist to the Royal Bethlem and Maudsley Hospitals and Senior Lecturer at the Institute of Psychiatry, London. He is a principal psychiatric authority on stalking and the co-author of the leading psychiatric textbook on the subject, Stalkers and their Victims, which won the Guttmacher prize in 2001 from the American Psychiatric Association.
2. See also: Mullen P E, Lester G. Vexatious litigants and unusually persistent complainants and petitioners: from querulous paranoia to querulous behaviour. Behav Sci Law 2006;24(3):333-49.
3. Lester G, Wilson B, Griffin L, et al. Unusually persistent complainants. Br J Psychiatry 2004;184:352–56.
31 August 2016
Practice
ELDER HEALTH: Use it or lose it - challenging balance during activity prevents later falls
1. Kwan MM, Tsang WW, Lin SI, et al. Increased concern is protective for falls in Chinese older people: the chopstix fall risk study. J Gerontol A Biol Sci Med Sci 2013;68(8):946–53.
2. Mansfield A, Wong JS, Bryce J, et al. Does perturbation-based balance training prevent falls? Systematic review and meta-analysis of preliminary randomized controlled trials. Phys Ther 2015;95(5):700–09.
VACCINES: Global vaccine initiatives seek to reduce disease burden
WHO. Meeting of the Strategic Advisory Group of Experts on immunization, October 2016– conclusions and recommendations. Weekly Epidemiological Record 2015;90(50);681-700. Accessed 5 July 2016. http://www.who.int/wer/2015/wer9050.pdf?ua=1
WHO. Meeting of the Strategic Advisory Group of Experts on immunization, April 2016 – conclusions and recommendations. Weekly Epidemiological Record 2016;91(21);265–84. Accessed 5 July 2016 http://www.who.int/wer/2016/wer9121.pdf?ua=1
CDC. Microneedle Patch for Measles Vaccination Could Be a Game Changer: Promises to Increase Reach of Immunization Coverage Globally. Press Release Monday, April 27, 2015 http://www.cdc.gov/media/releases/2015/p0427-microneedle-patch.html
EAR, NOSE & THROAT: HPV-related oropharyngeal cancer - older men most at risk
1. Pytynia KB, Dahlstrom KR, Sturgis EM. Epidemiology of HPV-associated oropharyngeal cancer. Oral Oncol 2014;50(5):380–86.
2. Chelimo C, Elwood JM. Sociodemographic differences in the incidence of oropharyngeal and oral cavity squamous cell cancers in New Zealand. Aust N Z J Public Health 2015;39(2):162–67.
3. Scudellari M. HPV: Sex, cancer and a virus. Nature News 2013;503:330–32.
4. Marur S, D'Souza G, Westra WH, et al. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 2010;11(8):781–89.
5. Gillison ML, D'Souza G, Westra W, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008;100:407–20.
6. Graboyes EM, Sinha P, Thorstad WL. Management of human papillomavirus–related unknown primaries of the head and neck with a transoral surgical approach. Head Neck 2015;37(11):1603–11.
7. Fakhry C, D’Souza G. Discussing the diagnosis of HPV-OSCC: common questions and answers. Oral Oncol 2013;49:863–71.
8. Herrero R, Quint W, Hildesheim A. Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. PLoS One 2013;8(7):e68329.
HOW TO TREAT Low back pain
1. Australian Acute Musculoskeletal Pain Guidelines Group. Evidence-based management of acute musculoskeletal pain. Brisbane: Australian Academic Press; 2003.
2. Bogduk N, McGuirk B. Pain Research and Clinical Management Series, volume 13. Medical management of acute and chronic low back pain. An evidence-based approach. Elsevier; 2002.
3. Bogduk N. On the definitions and physiology of back pain, referred pain, and radicular pain. Pain 2009;147:17–19.
4. Chou R et al. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Internal Med 2007;147(7): 478–91.
5. Deyo RA et al. Low back pain in primary care. BMJ 2014;349: g4266.
6. Indahl A. Low back pain: diagnosis, treatment, and prognosis. Scand J Rheumatol 2004;33:199–209.
17 August 2016
Practice
MEDICOLEGAL: Specifying standards, constructive criticism can invoke "the B word"
1. Royal Australasian College of Surgeons Expert Advisory Group on Discrimination, Bullying and Sexual Harassment. www.surgeons.org/media/22045685/EAG-Report-to-RACS-Draft-08-Sept-2015.pdf See also Brown R. “Widespread problem of harassment and bullying for resident doctors”: survey NZ Doctor, www.nzdoctor.co.nz/news/2015/May-2015/29
2. Message from the Chief of Army, Lieutenant General David Morrison, AO, to the Australian Army following the announcement on Thursday, 13 June 2013 of civilian police and Defence investigations into allegations of unacceptable behaviour by Army members. https://www.youtube.com/watch?v=QaqpoeVgr8U
FROM THE LAB: Laboratory overtesting - when it's not okay to tick all of the boxes
1. van Walraven C, Naylor CD. Do we know what inappropriate laboratory utilization is? A systematic review of laboratory clinical audits. JAMA 1998;280:550–58.
2. Lippi G et al. Effectiveness of a computerized alert system based on re-testing intervals for limiting the inappropriateness of laboratory test requests. Clin Biochem 2015;48;1174–76.
3. Djulbegovic B, Paul A. From efficacy to effectiveness in the face of uncertainty: indication creep and prevention creep. JAMA 2011;305;2005–06.
4. Fryer AA, Smellie WSA. Managing demand for laboratory tests: a laboratory toolkit. J Clin Pathol 2013;66:62–72.
5. Fryer AA and Hanna FW. Managing demand for pathology tests: financial imperative or duty of care? Ann Clin Biochem 2009;46:435–37.
6. Gopal Rao G, Crook M, Tillyer ML. Pathology tests: is the time for demand management ripe at last? J Clin Pathol 2003;56:243–48.
7. Morgan D J et al. Setting a research agenda for medical overuse. BMJ 2015:351:h4534.
8. Royal Australian College of General Practitioners (RACGP). Position Statement: Responding to patient requests for tests not considered clinically appropriate. http://www.racgp.org.au/support/policies/clinical-and-practice-management/appropriate-diagnostic-testing/
SPORTS MEDICINE: Longer rest from exercise advised after infectious mononucleosis
1. Bartlett A, Williams R, Hilton M. Splenic rupture in infectious mononucleosis: A systematic review of published case reports. Injury 2016;47:531–38.
2. Dommerby H, Stangerup SE, Stangerup M, et al. Hepatosplenomegaly in infectious mononucleosis, assessed by ultrasonic scanning. J Laryngol Otol 1986;100:573–79.
3. Shephard R. Exercise and the athlete with infectious mononucleosis. Clin J Sport Med 2016; 22 June online.
FIRST TIME: The first time you experience burn-out in general practice
1. Peckham C. Physician burnout: it just keeps getting worse. Medscape Family Medicine, 26 Jan 2015. Available online at http://www.medscape.com/viewarticle/838437
2. RNZCGP. The GP workforce. Available online at http://www.rnzcgp.org.nz/RNZCGP/Publications/The_GP_workforce/RNZCGP/Publications/GP_workforce.aspx?hkey=a7341975-3f92-4d84-98ec-8c72f7c8e151
3. Bourg Carter S. The tell tale signs of burnout… Do you have them? Psychology Today 26 Nov 2013. Available online at https://www.psychologytoday.com/blog/high-octane-women/201311/the-tell-tale-signs-burnout-do-you-have-them
4. Mata D. Podcast: Are physician burnout & depression the same? The Doctor Paradox 24 Jul 2016. Available online at http://thedoctorparadox.com/
5. O’Connor K. How are you doctor? Medical Council News Dec 2008, issue 46. Available online at https://www.mcnz.org.nz/assets/News-and-Publications/Newsletter/DEC08.pdf
6. O’Dowd TC. Five years of heartsink patients in general practice. BMJ 1988;297:528. Available online at http://www.bmj.com/content/297/6647/528
CHILD HEALTH: Safe Sleep programme shows reduction in infant deaths
1. Carville O. Govt ignored warnings over baby deaths. New Zealand Herald 9 July 2016. Available online at http://m.nzherald.co.nz/nz/news/article.cfm?c_id=1&objectid=11670826
2. Cowan S. Their first 500 sleeps: a full report of the first three years of implementation of the Pepi-Pod Sleep Space Programme (2012–2014). Change for our Children, 2015. ISBN 978-1-877512-14-8. Available online (pdf) at http://www.changeforourchildren.co.nz/files/docs/pepi-pod%20programme/their%20first%20500%20sleeps.pdf (accessed on 16/07/2016).
3. Mitchell EA, Cowan S, Tipene‐Leach D. The recent fall in post‐perinatal mortality in New Zealand and the Safe Sleep Programme. Acta Paediatrica (early online publication) 18 July 2016 DOI: 10.1111/apa.13494. Available online at http://onlinelibrary.wiley.com/doi/10.1111/apa.13494/abstract
4. Hawe P. Lessons from complex interventions to improve health. Ann Rev Public Health 2015;36:307–23.
20 July 2016
Newsletters
COLLEGE OF PRIMARY HEALTH CARE NURSES: When patient-centred care isn’t business as usual
1. Boon A. (2012). Excellence Through Patient and Family Centred Care; Literature Review. Retrieved from http://www.bopdhb.govt.nz/media/3505/1.1%20Literature%20Review.pdf
2. Wilson H. Becoming patient-centred; A review. N Z Fam Physician 2008, (35)3,164-170.
3. Wikipedia. (2016). Hippocratic Oath. Retrieved from https://en.wikipedia.org/wiki/Hippocratic_Oath
4. Torpie K. Customer service vs patient care. Patient Experience Journal 2014;(1)2:6-8.
Practice
FIRST TIME: Twitter helps you find what you didn't know you didn't know
1. The Royal New Zealand College of General Practitioners. Continuing professional development. Details online at https://www.rnzcgp.org.nz/continuing-professional-development
2. Rumsfeld D, Unknown unknowns. Watch online at YouTube https://www.youtube.com/watch?v=GiPe1OiKQuk
3. Self Awareness LLP. Understanding the Johari Window model. Available online at http://www.selfawareness.org.uk/news/understanding-the-johari-window-model
4. Wikipedia. Flow (psychology). Available online at https://en.wikipedia.org/wiki/Flow_(psychology)
5. Carr N. Is Google making us stupid? The Atlantic July/August 2008. Available online at http://www.theatlantic.com/magazine/archive/2008/07/is-google-making-us-stupid/306868/
6. Therapeutics Education Collaboration. How to critically appraise an RCT in 10 minutes. Available online at https://therapeuticseducation.org/how-critically-appraise-rct-10-minutes
FROM THE LAB: Overtesting for enteric pathogens causes problems for the patient
1. Ministry of Health. Escherichia coli (E. coli). Ministry of Health, 2016. Available online at http://bit.ly/296xsRx
2. Frank C, Werber D, Cramer JP et al. Epidemic profile of shiga-toxin–producing Escherichia coli O104:H4 outbreak in Germany. N Engl J Med 2011;365:1771–80.
3. Balabanova Y, Klar S, Deleré Y et al. Serological evidence of asymptomatic infections during Escherichia coli O104:H4 outbreak in Germany in 2011. PLoS ONE 2013;8.
4. Agger M, Scheutz F, Villumsen S et al. Antibiotic treatment of verocytotoxin-producing Escherichia coli (VTEC) infection: a systematic review and a proposal. J Antimicrob Chemother 2015;70:2440–46.
5. bpac nz. Laboratory investigation of infectious diarrhoea. bpac nz, 2008.
6 July 2016
Practice
VACCINES: Immunising HIV-infected adults - New Zealand recommendations
1. British HIV Association. British HIV Association guidelines on the use of vaccines in HIV-positive adults 2015. Editor A M Geretti, Nov 2015, Available online at http://bit.ly/1UvwiLW
2. Centers for Disease Control and Prevention. Recommended adult immunization schedule – United States – 2016. Accessed 25 May 2016. Available online at http://www.cdc.gov/vaccines/schedules/downloads/adult/adult-schedule.pdf
3. Fonseca MO, Pang LW, Cavalheiro N et al. Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose. Vaccine 2005;23:2902–08.
4. Rey D, Piroth L, Wendling M-J et al. Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial. Lancet Infect Dis 2015;15:1283–91.
5. Kernéis S, Launay O, Turbelin C et al. Long-term immune responses to vaccination in HIV-infected patients: a systematic review and meta-analysis. Clin Infect Dis 2014:58(8):1130–39.
6. Centers for Disease Control and Prevention. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the advisory committee on immunization practices (ACIP). MMWR 12 October 2012;61(40):816–19.
7. Wallace MR, Brandt CJ, Earhart KC et al. Safety and immunogenicity of an inactivated hepatitis A vaccine among HIV-infected subjects. Clin Infect Dis 15 October 2004;39:1207.
8. Kratz MM, Weiss D, Ridpath A et al. Community based outbreak of Neisseria meningitidis serogroup C infection in men who have sex with men, New York City, New York, USA, 2010–2013. Emerg Infect Dis 2015;21(8):1379–86.
HEARTBEAT: Retiree finds HOPE for lower risk of cardiovascular event
1. Yusuf S, Lonn E, Pais P et al for the HOPE-3 investigators. Cholesterol lowering in intermediate-risk persons without cardiovascular disease. N Engl J Med 2016;374:2032–43.
Are you giving smokers a fair go? Getting the most out of NRT
Quit smoking: NRT advice sheet
22 June 2016
Practice
MENTAL HEALTH: Self-management teamlets improve patient health outcomes
1. Bodenheimer T, Laing BY. The teamlet model of primary care. Ann Fam Med 2007;5:5.
2. Stanford Medicine. Chronic Disease Self-Management Program (CDSMP). Available online at http://patienteducation.stanford.edu/
3. Bennett HD, Coleman EA, Parry C et al. Health coaching for patients with chronic illness. Fam Pract Manag 2010. Available online at http://www.aafp.org/fpm/20100900/p24
4. Battersby M, Reece M, Collins J et al. Chronic disease self-management education – an Australian experience. Sydney: National Chronic Disease Self-Management Conference Sharing Health Care, 2000.
5. Heisler M. Building peer support programs to manage chronic disease: seven models for success. California Healthcare Foundation, December 2006.
6. Langley GL, Moen R, Nolan TW et al. The improvement guide: a practical approach to enhancing organizational performance (2nd edn). San Francisco: Jossey-Bass, 2009.
8 June 2016
Practice
CHILD HEALTH: Measles elimination - a task for every general practice
1. Langmuir AD. Medical importance of measles. Am J Dis Child 1962;103(3):224–26.
2. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 1997;349:1269–76.
3. Simons E, Ferrari M, Fricks J, et al. Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data. Lancet 2012;379:2173–78.
4. Davidkin I, Valle M. Vaccine-induced measles virus antibodies after two doses of combined measles, mumps and rubella vaccine: a 12-year follow-up in two cohorts. Vaccine 1998;16(20):2052–57.
5. Gay NJ. The theory of measles elimination: implications for the design of elimination strategies. J Infect Dis 2004;189(S1):S27¬–35.
6. Roberts MG, Tobias MI. Predicting and preventing measles epidemics in New Zealand: application of a mathematical model. Epidemiol Infect 2000;124;279–87.
7. Ministry of Health July 2014 NZ MMR coverage http://www.stats.govt.nz/browse_for_stats/snapshots-of-nz/nz-social-indicators/Home/Health/childhood-immunisation.aspx)
8. Turner N. The challenge of improving immunization coverage: the New Zealand example. Expert Rev Vaccines 2012;11(1):9–11.
9. Vandermeulen C, Roelants M, Theeten H et al. Vaccination coverage in 14-year-old adolescents: documentation, timeliness and sociodemographic determinants. Pediatrics 2008;121(3):e428–34.
10. Gay N, Ramsay M, Cohen B et al. The epidemiology of measles in England and Wales since the 1994 vaccination campaign. Commun Dis Rep CDR Rev 1997;7:R17–21.
11. Morse DE, O'Shea M, Hamilton G et al. Outbreak of measles in a teenage school population: the need to immunise susceptible adolescents. Epidemiol Infect 1994;113:355–65.
12. Christenson B, Bottiger M. Measles antibody: comparison of longterm vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus. Vaccine 1994;12(20):129–33.
13. Guris D, McCready J, Watson JC et al. Measles vaccine effectiveness and duration of vaccine induced immunity in the absence of boosting from exposure to measles virus. Pediatr Infect Dis J 1996;15:1082–86.
OCCUPATIONAL HEALTH: "Doctor, do you think it could have been the sausage?"
1. Bouvard V, Loomis D, Guyton KZ et al. Carcinogenicity of consumption of red and processed meat. Lancet Oncol 2015;16(16):1599–600.
2. Chan DS, Lau R, Aune D et al. Red and processed meat and colorectal cancer incidence: meta-analysis of prospective studies. PLoS One 2011;6(6):e20456.
25 May 2016
Practice
CHILD HEALTH: Mana Kidz successfully reaches kids at risk of acute rheumatic fever
1. Bidwell S. Improving access to primary health care for children and youth: a review of the literature for the Canterbury Clinical network Child and Youth Workstream. Canterbury District Health Board, 2003. Available online at http://www.cph.co.nz/Files/AccessPrimaryCareChildrenYouth.pdf
2. Anderson P, King J, Moss M et al. Nurse-led school-based clinics for rheumatic fever prevention and skin infection management: evaluation of Mana Kidz programme in Counties Manukau. NZMJ 2016;129(1428):36-45.
3. Hoare K. General practice must enact UN treaty on children’s rights. New Zealand Doctor, 8 October 2014. p31.
4. Hoare K. Access to primary care is a child’s right says UN, but barriers may exist. New Zealand Doctor, 3 December 2014. p28.
5. Hoare K. Children at risk through disability or ethnicity have specific rights. New Zealand Doctor, 4 February 2015. p22.
6. Craig E, Adams J, Oben G et al. The health status of children and young people in New Zealand. Dunedin: New Zealand Child and Youth Epidemiology Service, 2013.
DERMATOLOGY: The mHealth era is here: Mobile dermatology applications
1. Kassianos AP, Emery JD, Murchie P et al. Smartphone applications for melanoma detection by community, patient and generalist clinician users: a review. Br J Dermatol 2015 Jun;172(6):1507–18. doi: 10.1111/bjd.13665. Epub 2015 May 6. Review. PubMed PMID: 25600815.
2. Maier T, Kulichova D, Schotten K et al. Accuracy of a smartphone application using fractal image analysis of pigmented moles compared to clinical diagnosis and histological result. J Eur Acad Dermatol Venereol 2015 Apr;29(4):663–67. doi: 10.1111/jdv.12648. Epub 2014 Aug 4. PubMed PMID: 25087492.
FIRST TIME: Using Te Reo in a patient consultation
1. Pitama S, Ahuriri-Driscoll A, Huria T et al. The value of te reo in primary care. J Prim Health Care 2011;3(2):123–27. Available online at http://bit.ly/21vfk6a
FROM THE LAB: Hypercalcaemia: Often incidental, it requires a thorough work-up
1. Twigt BA, Houweling BM, Vriens MR et al. Hypercalcemia in patients with bipolar disorder treated with lithium: a cross-sectional study. Int J Bipolar Disord 2013;1:18
2. Carroll MF, Schade DS. A practical approach to hypercalcemia. Am Fam Physic 2003;67(9):1959–66. Available online at http://www.aafp.org/afp/2003/0501/p1959.html
3. Ballehaninna UK, Nguyen SM, Chamberlain RS. Lithium associated hyperparathyroidism: An evidence based surgical approach. Surgical Sci 2011;(2):468–75.
4. Applewhite MK, Schneider DF. Mild primary hyperparathyroidism: A literature review. The Oncologist 2014;19:919–29.
5. Quinn JM, Matsumura Y, Train D et al. Cellular and hormonal mechanisms associated with malignant bone resorption. Lab Invest 1994;71:465.
6. Christensen SE, Nissen PH, Vestergaard P et al. Familial hypocalciuric hypercalcaemia: A review. Curr Opin Endocrinol Diabetes Obes 2011;18(6):359–70.
7. Koul PA, Ahmad SH, Ahmad F et al. Vitamin D toxicity in adults: A case series from an area with endemic hypovitaminosis D. Oman Med J 2011;26(3):201–04.
MEDICOLEGAL: Prophylactic record-keeping could see you cleared of a complaint
1. Medical Council Guidelines. The maintenance and retention of patient records, August 2008. www.mcnz.org.nz
2. Office of the Privacy Commissioner. Health Information Privacy Code 1994, Part III(6), Regulation 5.
3. New Zealand Government. Health Act 1956. Section 22F.
4. New Zealand Government. Health (Retention of Health Information) Regulations 1996.
MENTAL HEALTH: Maternal mental health: The opportunities and challenges
1. Wells JE, Oakley Browne MA et al. Prevalence, interference with life and severity of 12 month DSM-IV disorders in Te Rau Hinengaro: the New Zealand Mental Health Survey. Austr N Z J Psychiatry 2006 Jan 1;40(10):845–54.
2. Perinatal and Maternal Mortality Review Committee. Ninth annual report of the Perinatal and Maternal Mortality Review Committee: reporting mortality 2013. Wellington: Health Quality & Safety Commission, 2015.
3. Heron J, O'Connor TG, Evans J et al for the ALSPAC Study team. The course of anxiety and depression through pregnancy and the postpartum in a community sample. J Affect Disord 2004 May 31;80(1):65–73.
4. Cox JL, Murray D, Chapman G. A controlled study of the onset, duration and prevalence of postnatal depression. Br J Psychiatry 1993 Jul 1;163(1):27–31.
5. Blom E, Jansen P, Verhulst F et al. Perinatal complications increase the risk of postpartum depression. The Generation R Study. Br J Obstet Gynaecol 2010 Oct;117(11):1390–98.
6. Goodman SH, Rouse MH, Connell AM et al. Maternal depression and child psychopathology: a meta-analytic review. Clin Child Fam Psychol Rev 2011 Mar 1;14(1):1–27.
7. Lattimore KA, Donn SM, Kaciroti N et al. Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and effects on the fetus and newborn: a meta-analysis. J Perinatol 2005 Sep 1;25(9):595–604.
8. Malm H, Sourander A, Gissler M et al. Pregnancy complications following prenatal exposure to SSRIs or maternal psychiatric disorders: results from population-based national register data. Am J Psychiatry 2015 Aug 4;172(12):1224–32.
9. Boukhris T, Sheehy O, Mottron L et al. Antidepressant use during pregnancy and the risk of autism spectrum disorder in children. JAMA Pediatr 2015 Dec 14 :1–8.
11 May 2016
Practice
HEARTBEAT: Prophylactic aspirin not advised for atrial fibrillation patients
1. Camm AJ, Kirchhof P, Lip GY et al.; European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010;31:2369–429.
2. Freedman SB, Gersh BJ, Lip GYH. Misperceptions of aspirin efficacy and safety may perpetuate anticoagulant underutilization in atrial fibrillation Eur Heart J 2015;36:653–56.
3. Atrial fibrillation: management. NICE Guidelines [CG 180] June 2014. Available online at http://guidance.nice.org.uk/CG180
ELDER HEALTH: Are older people being asked to bite off more than they can chew?
1.CBG Health Research. Our Older People’s Oral Health. Key Findings of the 2012 New Zealand Older People’s Oral Health Survey. Auckland: CBG Health Research. 2015. http://bit.ly/1QoyeUp
VACCINES: Protecting the elderly from disease: Which vaccines to recommend?
1. Institute of Environmental Science and Research Ltd (ESR). Surveillance report: Invasive pneumococcal disease in New Zealand, 2013. Porirua: ESR; 2014.
2. Jackson LA, Gurtman A, Rice K et al. Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine. Vaccine 2013 31(35):3585–93.
3. Canadian Agency for Drugs and Technologies in Health. Conjugate pneumococcal vaccine (13-valent) for immunocompromised populations: A review of the clinical evidence [Internet]. CADTH Rapid Response Reports March 27, 2014 [accessed 6 April 2016].
4. Hales CM, Harpaz R, Ortega-Sanchez I, Bialek SR. Update on recommendations for use of herpes zoster vaccine. Morbidity and Mortality Weekly Report August 22, 2014;63(33):729–31.
5. Ridda I, Yin JK, King C et al. The importance of pertussis in older adults: A growing case for reviewing vaccination strategy in the elderly. Vaccine 2012;30:6745–52.
6. Ministry of Health. Immunisation handbook 2014. Wellington: Ministry of Health, 2014. Available online at http://www.health.govt.nz/publication/immunisation-handbook-2014
27 April 2016
Practice
FIRST TIME: Assess relapse risk the first time you stop a patient's antidepressant
1. Bain KT, Holmes HM, Beers MH et al Discontinuing medications: a novel approach for revising the prescribing stage of the medicine use process. J Am Geriatr Soc 2008;56(10):1946–52.
2. National Institute for Health and Care Excellence. Depression in adults: recognition and management. NICE guidelines [CG90] October 2009. Available online at https://www.nice.org.uk/guidance/cg90
3. Schmall L, Veltman DJ, Hibar DP for the ENIGMA MDD working group. Subcortical brain volume abnormalities in major depressive disorder: prospective meta-analytic findings from the enigma major depressive disorder working group. Society for Neuroscience (SfN) Conference 2014. Conference abstract from http://enigma.ini.usc.edu/publications/
FROM THE LAB: HPV now the othodoxy for cervical screening, despite the evidence
1. Smith M, Walker R, Canfell K. National Cervical Screening Programme annual report 2012. Wellington: Ministry of Health, 2012.
2. Zhou H, Mody R, Luna E et al. Clinical performance of the Food and Drug Administration-approved high-risk HPV test for the detection of high-grade cervicovaginal lesions. Cancer Cytopathol 2016. DOI: 10.1002/cncy.21687. Article first published online: 15 Jan 2016.
3. Cervical Cancer Audit NZ and University of Auckland. Cervical Cancer Audit: Screening of women with cervical cancer 2000–2002. Wellington: Ministry of Health, 2004.
4. Kitchener HC, Gilham C, Sargent A et al. A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: Extended follow up in the ARTISTIC trial. Eur J Cancer 2011;47:864–71.
5. Bulkmans N, Berkhof J, Rozendaal L et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet 2007;370:1764–72.
6. Ronco G, Giorgi-Rossi P, Carozzi F et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 2010;11:249–57.
7. Naucler P, Ryd W, Tornberg S et al. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. New Engl J Med 2007;357:1589–97.
8. Dillner J, Rebolj M, Birembaut P et al. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: Joint European cohort study. BMJ 2008;337:969–72.
9. Ronco G, Dillner J, Elfstrom KM et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: Follow-up of four European randomised controlled trials. Lancet 2014;383:524–32.
10. Kinney W, Wright TC, Dinkelspiel HE et al. Increased cervical cancer risk associated with screening at longer intervals. Obstet Gynecol 2015;125:311–15.
11. Austin RM, Onisko A. Increased cervical cancer risk associated with extended intervals after negative human papillomavirus test results: Bayesian risk estimates using the Pittsburgh Cervical Cancer Screening model. J Am Soc Cytopathol 2016;5:9–14.
12. Austin RM. HPV primary screening: Unanswered questions. Cytopathology 2016;27:73–74.
13. Blatt AJ, Kennedy R, Luff RD et al. Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices. Cancer Cytopathol 2015;123:282–88.
14. Wright TC, Stoler MH, Behrens CM et al. Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test. Gynecol Oncol 2015;136:189–97.
15. Woodard A, Austin RM, Li Z et al. Prevalence of HPV 16/18 genotypes and histopathologic follow-up outcomes in women with negative cytology and positive high-risk HPV test results. J Am Soc Cytopathol 2015;4:261–66.
MEDICOLEGAL: Privacy breach raises suspicion in a patient-doctor relationship
1. Office of the privacy commissioner. Case Note 248601 [2013] NZ PrivCmr 4 : Medical practice mitigates future harm after data breach. Available online at bit.ly/2280fWT
MENTAL HEALTH: Alcohol misuse: How many drinks in the average seven-day period?
1. Wells JE, Baxter J, Schaaf D. Substance use disorders in Te Rau Hinengaro: The New Zealand Mental Health Survey. Final Report. Wellington: Alcohol Advisory Council of New Zealand, 23 November 2006.
2. Furtwaengler de Visser. Lack of international consensus in low-risk drinking guidelines. Drug Alcohol Rev 2013;32:11–18.
3. Callinan S. How big is a self-poured glass of wine for Australian drinkers? Drug Alcohol Rev 2015;34:207–10.
4. Sellman D, Connor J. Too many risky drinkers; too little alcohol law reform. N Z Med J 29 August 2014;127:1401.
13 April 2016
Practice
CHILD HEALTH: Vaccine-hesitant parents show common behavioural traits
1. World Health Organization. Report of the SAGE working group on vaccine hesitancy. WHO, 2014. Available online at http://www.who.int/immunization/sage/meetings/2014/october/1_Report_WORKING_GROUP_vaccine_hesitancy_final.pdf
2. World Health Organization Regional Office for Europe. The guide to tailoring immunization programmes (TIP). WHO, 2013. Available online at http://www.euro.who.int/en/health-topics/disease-prevention/vaccines-and-immunization/publications/2013/guide-to-tailoring-immunization-programmes
3. Leask J. Target the fence-sitters. Nature 2011;473:443–45.
4. Betsch C, Böhm R, Chapman GB. Using behavioural insights to increase vaccination policy effectiveness. Policy Insights from the Behavioural and Brain Sciences 2015;2(1):61–63.
5. Cook J, Lewandowsky S. The debunking handbook. St Lucia, Australia: University of Queensland, 2011 November 5. ISBN 978-0-646-56812-6. Available online at http://www.skepticalscience.com/Debunking-Handbook-now-freely-available-download.html
6. Lewandowsky S, Ecker UKH, Seifert CM et al. Misinformation and its correction: continued influence and successful debiasing. Psychol Sci Public Interest 2012;13(3):106–31.
30 March 2016
Practice
16 March 2016
Practice
CHILD HEALTH: Immunisation conversations: ensure you have a positive effect
1. Andre FE, Booy R, Bock HL et al. Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Org 2008;86:140–46.
2. Ministry of Health. National and DHB immunisation data. Register data published for December 2015. Available online at http://www.health.govt.nz/our-work/preventative-health-wellness/immunisation/immunisation-coverage/national-and-dhb-immunisation-data
3. Keane MT1, Walter MV, Patel BI et al. Confidence in vaccination: a parent model. Vaccine 2005 Mar 31;23(19):2486–93.
4. World Health Organization. Report of the SAGE working group on vaccine hesitancy, WHO, 2014. Available online (pdf) at http://www.who.int/immunization/sage/meetings/2014/october/1_Report_WORKING_GROUP_vaccine_hesitancy_final.pdf
5. World Health Organization. The guide to tailoring immunization programmes (TIP): Increasing coverage of infant and child vaccination in the WHO European Region. WHO, 2013. Available online at http://www.euro.who.int/en/health-topics/disease-prevention/vaccines-and-immunization/publications/2013/guide-to-tailoring-immunization-programmes
6. Ministry of Health. Immunisation Handbook 2014. MOH, 2014.
7. Centers for Disease Control Plain language tools. Available online at http://www.cdc.gov/healthliteracy/developmaterials/plainlanguage.html
8. Immunize British Colombia. The A-S-K approach. Available online at http://www.bccdc.ca/health-professionals/clinical-resources/immunization
ELDER HEALTH: Octogenarians today have lived through remarkable times
1. Salmond A. Between worlds: early exchanges between Maori and Europeans 1773–1815 (1st edition). Auckland: Viking, 1997.
2. Kunitz S. Disease and social diversity: the European impact on the health of non-Europeans. New York: Oxford University Press Inc, 1994.
3. Reid P, Robson B. The state of Maori health. In: Mulholland M (ed). State of the Maori nation: twenty-first century issues in Aotearoa. Auckland: Reed, 2006.
4. Sutch WB. The quest for security in New Zealand 1840–1966. London: Oxford University Press, 1966.
5. Ministry of Health. 2006/07 New Zealand Health Survey Adult Questionnaire, Final CAPI version. Wellington: Ministry of Health, 2008.
6. Smith B, Parsons M, Hand J. War leaves an enduring legacy in combatants’ lives. J Gerontological Social Work 2014;57(8).
7. Elder GH Jr, Clipp EC. Combat experience and emotional health: impairment and resilience in later life. J Personality 1989 Jun;57(2):311–41.
8. Smith B. Ordinary men: extraordinary times. An exploration of the impact of combat experience on World War Two Royal New Zealand Air Force aircrew across the life course from the perspectives of the veterans, their spouse/partner, siblings, children and grandchildren. Auckland: University of Auckland, 2011.
9. Allen RS, Haley PP, Harris GM et al. Resilience: definitions, ambiguities, and applications. In: Resnick B, Gwyther LP, Roberto KA (eds). Resilience in aging: concepts, research, and outcomes. New York: Springer Science+Business Media, 2011.
HEARTBEAT: Blood pressure targets for the hypertensive patient in 2016
1. SPRINT Research Group, Wright JT Jr, Williamson JD, Whelton PK et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015 Nov 26;373(22):2103–16.
2. Lim SS, Vos T, Flaxman AD et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012 Dec 15;380(9859):2224–60.
3. ACCORD Study Group, Cushman WC, Evans GW, Byington RP et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010 Apr 29;362(17):1575–85.
4. Xie X, Atkins E, Lv J et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis. Lancet 2016 Jan 30;387:435–43.
5. Chobanian AV. Time to reassess blood-pressure goals. N Engl J Med 2015 Nov 26;373(22):2093–95.
6. New Zealand Guidelines Group. Guidance on the management of type 2 diabetes 2011. Wellington: NZGG, 2011 [electronic resource]. Available online at http://www.moh.govt.nz/notebook/nbbooks.nsf/0/60306295DECB0BC6CC257A4F000FC0CB?OpenDocument
2 March 2016
Practice
CHILD HEALTH: Oral formulations for children: ‘Simple as’ – yeah, right
1. European Medicines Agency. Paediatric formulations. Available online at http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000045.jsp&mid=WC0b01ac0580925cc9 Accessed 23 Nov 2015.
2. McIntyre J, Conroy S, Avery A et al. Unlicensed and off label prescribing of drugs in general practice. Arch Dis Child 2000 Dec;83(6):498–501.
3. Conroy S, McIntyre J, Choonara I. Unlicensed and off label drug use in neonates. Arch Dis Child Fetal Neonatal Ed 1999 Mar;80(2):F142–F145.
4. BPAC NZ. Avoiding medication errors in children: a practical guide for healthcare professionals accessed. Available online at http://www.bpac.org.nz/BPJ/2010/July/docs/BPJ_29_errors_guide_pages_8-18.pdf Accessed 22 Dec 2015.
5. Woods D. Risk assessment of paediatric formulations: alternatives to compounding. [Powerpoint presentation].
FIRST TIME: The first time a patient asks you for medicinal cannabis
1. Iskedjian M, Bereza B, Allan G et al. Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain. Curr Med Res Opin 2007;23(1):17–24.
2. Wilkinson ST, Yarnell S, Radhakrishnan R et al. Marijuana legalization: impact on physicians and public health. Ann Rev Med 2016;67:453–66.
3. TVNZ Onenews. Terminally ill Helen Kelly calls for a referendum on legalising cannabis. 11 January 2016. Available online at Onenewsnow: https://www.tvnz.co.nz/one-news/new-zealand/terminally-ill-helen-kelly-calls-for-referendum-on-legalising-cannabis
4. Samantha Hayes, 3D. Alex Renton’s mother used cannabis oil weeks before approval. 19 July 2015. Available online at Newshub: http://www.3news.co.nz/tvshows/3d/sick-teens-mother-used-cannabis-oil-weeks-before-approval-2015071915#axzz3ymNhYgAF
5. Ministry of Health. Medicinal cannabis. Available online at http://www.health.govt.nz/our-work/regulation-health-and-disability-system/medicines-control/medicinal-cannabis
6. eMC. Sativex oromucosal spray. Available online from Datapharm at http://www.medicines.org.uk/emc/medicine/23262
MENTAL HEALTH: Health is not always a personal value for the patient
1. Robinson PJ, Reiter JT. Behavioral consultation and primary care: a guide to integrating services. New York: Springer, 2007.
2. Hayes SC, Strosahl KD, Wilson KG. Acceptance and commitment therapy: an experiential approach to behaviour change. New York: Guildford Press, 1999.
SPORTS MEDICINE: Head injury – a headache to deal with, despite clear guidelines
1. Consensus statement on concussion in sport: the 4th International Conference on Concussion in Sport held in Zurich, November 2012. Br J Sports Med 2013;47:250–58. doi:10.1136/bjsports-2013-092313
2. Concussion in Sport Group. Sports Concussion Assessment Tool – 3rd edition. Br J Sports Med 2013. Available online at http://bjsm.bmj.com/content/47/5/259.full.pdf
3. Doyle P. André Villas-Boas blasts 'incompetent critics' in Hugo Lloris concussion row. The Guardian 6 November 2013. Available online at http://www.theguardian.com/football/2013/nov/06/hugo-lloris-available-tottenham-concussion
17 February 2016
Practice
VACCINES: Immunisations for patients with renal disease in New Zealand
1. Australia and New Zealand Dialysis and Transplant Registry (ANZDATA). 37th Report – Chapter 3: Mortality in end stage kidney disease. Adelaide: ANZDATA, 2015. Available online at www.anzdata.org.au
2. Kato S, Chmielewski M, Honda H et al. Aspects of immune dysfunction in end stage renal disease. Clin J Am Soc Nephrol 2008;3(5):1526–33.
3. Janus N, Vacher LV, Karie S et al. Vaccination and chronic kidney disease. Nephrol Dial Transplant 2008;23(3):800–7.
4. Guo H, Liu J, Collins AJ et al. Pneumonia in incident dialysis patients – the United States Renal Data System. Nephrol Dial Transplant 2008;23(2):680–86.
5. Vandecasteele SJ, Ombelet S, Blumental S et al. The ABC of pneumococcal infections and vaccination in patients with chronic kidney disease. Clin Kid J 2015;8(3):318–24.
6. Bond TC, Spaulding AC, Krisher J et al. Mortality of dialysis patients according to influenza and pneumococcal vaccination status. Am J Kid Dis 2012;60(6):959–65.
7. National Renal Advisory Board. New Zealand dialysis and transplantation audit 2012 and 2013. NRAB: May 2015. Available online at http://www.health.govt.nz/about-ministry/leadership-ministry/clinical-groups/nationalrenal-advisory-board [Accessed January 2016]
ELDER HEALTH: A programme to keep people with mild dementia in the game
1. Van Doorn C, Gruber-Baldini AL, Zimmerman S et al. Dementia as a risk factor for falls and fall injuries among nursing home residents. J Am Geriatr Soc 2003;51(9):1213–18.
2. Health Quality and Safety Commission New Zealand. Atlas of healthcare variation (falls domain). Wellington: Health Quality and Safety Commission New Zealand, 2015 [3 July 2015]. Available from http://www.hqsc.govt.nz/our-programmes/health-quality-evaluation/projects/atlas-of-healthcare-variation/falls/
3. Suttanon P, Hill K, Said C et al. Can balance exercise programmes improve balance and related physical performance measures in people with dementia? A systematic review. Eur Rev Aging Physical Activity 2010;7(1):13–25.
4. Woods B, Aguirre E, Spector A et al. Cognitive stimulation to improve cognitive functioning in people with dementia. Cochrane Database Syst Rev 2012;2(2:CD005562.).
5. Herholz S, Herholz R, Herholz K. Non-pharmacological interventions and neuroplasticity in early stage Alzheimer’s disease. Expert Rev Neurother 2013;13(11):1235–45.
6. Cheung G, Peri K. Cognitive stimulation therapy: A New Zealand pilot. Auckland: Te Pou o TeWhakaaro Nui | Te Pou, 2014.
7. Spector A, Thorgrimsen L, Woods BOB et al. Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia: randomised controlled trial. Br J Psychiatry 2003;183(3):248–54.
HEARTBEAT: Retiree with atrial flutter wary of the treatment risks
1. Guidelines for the management of atrial fibrillation. Eur Heart J 2010;31:2369–429. Available online at http://eurheartj.oxfordjournals.org/content/31/19/2369
2. Corrigendum to: “Guidelines: 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation” [Eur Heart J (2012) 33 (21):2719–47; doi:10.1093/eurheartj/ehs253] Eur Heart J Sep 2013;34(36):2850–51. DOI: 10.1093/eurheartj/eht291, Table 3. Available online at http://eurheartj.oxfordjournals.org/content/34/36/2850
3. Connolly SJ, Ezekowitz MD, Yusuf S et al and the RE-LY Steering Committee and Investigators. N Engl J Med 2009;361:1139–51. Available online at http://www.nejm.org/doi/full/10.1056/NEJMoa0905561
3 February 2016
Practice
CHILD HEALTH: HEARTS provides a window into the minds of children
1. New Zealand Guidelines Group. Evidence-based best practice guideline: Identification of common mental disorders and management of depression in primary care. Wellington: NZGG/Ministry of Health, 2008. Available online at http://bit.ly/1MVk3HX
MEDICOLEGAL: A betrayal! It's not really like that, if you can explain
1. New Zealand Government. Privacy Principle 2, Privacy Act 1993.
2. Maas R, Ventura R, Kretzschmar C et al. Syncope, driving recommendations and clinical reality: survey of patients. BMJ 4 Jan 2003;326(7379):21.
MENTAL HEALTH: Checking values: New questions and more meaningful consults
1. Harris R. ACT made simple. An easy-to-read primer on acceptance and commitment therapy. Oakland (CA): New Harbinger Publications Inc, 2009.
2. A-Tjak JG, Davis ML, Morina N et al. A meta-analysis of the efficacy of acceptance and commitment therapy for clinically relevant mental and physical health problems. Psychother Psychosom 2015;84(1):30–36.
3. Dahl JC, Plumb JC, Stewart I et al. The art and science of valuing in psychotherapy. Oakland (CA): New Harbinger Publications Inc, 2009.
2015
16 December 2015
Practice
MEDICOLEGAL: Whether letting your hair down or working through, know the risks
1. Reason J. Human error. Cambridge: Cambridge University Press, 1990.
2. Privacy commissioner. Privacy Breach Guidelines: key steps for agencies. February 2008. Available online at https://www.privacy.org.nz/news-and-publications/guidance-resources/privacy-breach-guidelines-2/
3. Privacy commissioner. Case Note 248601 [2013] NZ Priv Cmr 4. Available online at https://www.privacy.org.nz/news-and-publications/case-notes-and-court-decisions/case-note-248601-2013-nz-privcmr-4-medical-practice-mitigates-future-harm-after-data-breach/
SEXUAL HEALTH: Family violence affects women’s sexual and reproductive health
1. Fanslow J, Robinson E. Violence against women in New Zealand: prevalence and health consequences. N Z Med J 2004;117.
2. Ministry of Health. Recognising and responding to partner abuse: a resource for general practices. Wellington: Ministry of Health, 2 June 2003.
3. Bay of Plenty DHB. Partner abuse/family violence – routine screening of women and main caregiver policy 1.6.3.
25 November 2015
Practice
CHILD HEALTH: Scope for greater use of meningococcal B and C vaccines
1. Clark HF, Offit PA, Parashar UD. Meningococcal vaccines. In: Plotkin SA, Orenstein WA, Offit PA,editors. Vaccines: expert consult. 6th ed. Saunders (Elsevier Inc), 2013.
2. Meningitis symptoms. The Meningitis Centre Australia. Available online at http://www.meningitis.com.au/signs_and_symptoms/symptoms.phtml
3. Mills G, Bell A. Meningococcal disease in New Zealand. N Z Med J 2013;126:1373.
4. Ministry of Health. Meningococcal disease. Updated 16 September 2015. Available online at http://www.health.govt.nz/your-health/conditions-and-treatments/diseases-and-illnesses/meningococcal-disease
5. Ministry of Health. Immunisation handbook 2014. Wellington: Ministry of Health, 2014. Available online at http://www.health.govt.nz/publication/immunisation-handbook-2014
6. National Centre for Immunisation Research & Surveillance. Fact sheet: Meningococcal vaccines for Australians. NCIRS, June 2014.
7. Lopez L, Sherwood J. The Epidemiology of meningococcal disease in New Zealand in 2013/2014. Wellington, Institute of Environmental Science and Research Ltd (ESR).
8. Reid S. “Meningococcal Vaccination”, presented at the Infectious Diseases and Immunisation Special Interest Group, The Paediatric Society of New Zealand 66th annual scientific meeting. Napier, 18 November 2014.
9. Novartis. Novartis vaccine Bexsero® sees high uptake in first large-scale public vaccination program to help protect against devastating meningitis B [press release]. Novartis, 2014 [cited 2014 October]; Available online at https://www.novartis.com/news/media-releases/novartis-vaccine-bexsero%C2%AE-sees-high-uptake-first-large-scale-public-vaccination
10. Christensen H, Trotter CL, Hickman M et al. Re-evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling study. Br Med J 2014;349:g5725.
11. Britain leads the way with meningococcal vaccination programmes. Pharm J 27 June/4 July 2015;294 (7868/9). Online publication. DOI: 10.1211/PJ.2015.20068801
ELDER HEALTH: Mobility and dementia – better to walk than just stand
1. Rapp K, Klenk J, Benzinger P et al. Physical performance and daily walking duration: associations in 1271 women and men aged 65-90 years. Ageing Clin Exp Res 2012;24(5):455–60.
2. Lipsitz LA, Goldberger AL. Loss of ‘complexity’ in aging: potential applications of fractals and chaos theory to senescence. JAMA 1992;267:1806–09.
3. Schwenk M, Hauer K, Zieschang T et al. Sensor-derived physical activity parameters can predict future falls in people with dementia. Gerontology 2014:60(6);483–92.
11 November 2015
Practice
CHILD HEALTH: Severe childhood asthma – a team approach with home visits
1. Rottier B, Eber E, Hedlin,G et al. Monitoring asthma in childhood: management-related issues. Eur Respir Rev 2015 Jun;24(136):194–203.
2. Dick S, Doust E, Cowie H et al. Associations between environmental exposures and asthma control and exacerbations in young children: a systematic review. BMJ Open 2014;4: e003827
MEDICOLEGAL: Being an expert can be valuable professional development
1. Hugh TB, Tracy GD. Hindsight bias in medico-legal expert reports. Med J Austr 2002;176(6):277–78.
SPORTS MEDICINE: Neck and back pain in young adults is mostly postural
1. Kanji G. Treat your neck pain, headache and migraine. Wellington: Pain Publications, 2015
2. Dang L, Liu Z. A review of current treatment for lumbar disc herniation in children and adolescents. Eur Spine J 2012;19(2):205–14.
28 October 2015
Practice
27 October (online)
NZ's first National Respiratory Strategy to launch in Wgtn next week,
Data References[for By the Numbers box]
World Health Organization. 2014.Noncommunicable diseases country profiles 2014.Geneva: WHO Document Production Services
Telfar Barnard, L., Baker, M., Pierse, N., & Zhang, J. (2015).The impact of respiratory disease in New Zealand: 2014 update.Wellington: Asthma Foundation.
Craig, E., Reddington, A., Wicken, A., Oben, G., & Simpson, J. (2013).Child Poverty Monitor 2013: Technical report (updated 2014).Dunedin: NZ Child and Youth Epidemiology Service, University of Otago.
14 October 2015
Practice
MEDICOLEGAL: A look at the airline industry a good thing for professionalism
1. R v Ramstead [1992] 2 AC 92, [1992] 1 NZLR 513 (PC)
2. Medical Council Guidelines. What to do when you have concerns about a colleague. Wellington: Medical Council of New Zealand, December 2010. Available online at https://www.mcnz.org.nz/assets/News-and-Publications/Statements/Concerns-about-a-colleague.pdf
SEXUAL HEALTH: Gender dysphoria: Be a 'compass' not the gender police
1. American Psychiatric Association. Desk reference to the diagnostic criteria from DSM-5. Arlington, VA: American Psychiatric Association, 2013. p216.
2. Dresher J. Gender policing in the clinical setting: discussion of Sandra Silverman’s “The colonised mind: gender, trauma, and mentalization”. Psychoanalytic Dialogues 2015;25:67-76.
SPORTS MEDICINE: Are concussions the cause of chronic traumatic encephalopathy?
1. Kiernan PT, Montenigro PH, Solomon TM, McKee AC. Chronic traumatic encephalopathy: a neurodegenerative consequence of repetitive traumatic brain injury. Semin Neurol 2015 Feb;35(1):20–28.
2. Maroon JC, Winkelman R, Bost J et al. Chronic traumatic encephalopathy in contact sports: a systematic review of all reported pathological cases. PloS One 11 Feb 2015. DOI:10.1371/journal.pone.0117338
3. Davis GA, Castellani RJ, McCrory P. Neuro-degeneration in sport. Neurosurgery 2015;76:643-56.
4. Savica R, Parisi JE, Wold LE et al. High school football and risk of neurodegeneration: a community-based study. Mayo Clin Proc 2012 Apr;87(4):335-40.
30 September 2015
Practice
VACCINES: Vaccinations by pharmacists meet the need of a time-poor public
1. Pharmacybrands Ltd. Influenza vaccinations available from selected Pharmacybrands pharmacies [media release]. 17 Aug 2011. Available online at http://www.pharmacytoday.co.nz/media-releases/2011/august-2011/17/influenza-vaccinations-available-from-selected-pharmacybrands-pharmacies.aspx
2. Ministry of Health. 2014 Immunisation Handbook. Appendix 3: Immunisation standards for vaccinators and guidelines for organisations offering immunisation services. Wellington: New Zealand Ministry of Health.
3. MedSafe. Reclassification of vaccines. 11 Apr 2014. Wellington: Ministry of Health. Available online at http://www.medsafe.govt.nz/profs/class/ReclassificationOfVaccines.asp
4. Green Cross Health Ltd. Vaccination. 2014 [accessed 31 Aug 2015]. Available online at http://www.greencrosshealth.co.nz/pharmacy-service/vaccination?i=5
5. Beal S. Waikato DHB funding free flu jabs. Pharmacy Today [Online News, 9 Apr 2015, www.pharmacytoday.co.nz].
6. Waikato DHB. Free flu vaccinations at pharmacies a New Zealand First. 21 Apr 2015. Waikato DHB.
ELDER HEALTH: Elderly need a good, varied diet to avoid micronutrient deficiency
1. University of Otago, Ministry of Health. A focus on nutrition: key findings of the 2008/09 New Zealand Adult Nutrition Survey. Wellington: Ministry of Health, 2011.
2. Bailey RL, Dodd KW, Goldman JA et al. Estimation of total usual calcium and vitamin D intakes in the United States. J Nutr 2010;140(4):817–22.
3. Zhu K, Devine A, Suleska A et al. Adequacy and change in nutrient and food intakes with aging in a seven-year cohort study in elderly women. J Nutr Health Aging 2010;14(9):723–29.
4. Ahmed M, Arcand J, Schermel A et al. Analysis of the dietary intakes of Canadian adults. FASEB J 2015;29(1 Supplement):903–24.
5. National Health and Medical Research Council. Nutrient reference values for Australia and New Zealand. Canberra: NHRMC, 2006.
6. Orchard TS, Larson JC, Alghothani N et al. Magnesium intake, bone mineral density, and fractures: results from the Women’s Health Initiative Observational Study. Am J Clin Nutr 2014;99(4):926–33.
7. Barbagallo M, Belvedere M, Dominguez LJ. Magnesium homeostasis and aging. Magnes Res 2009;22(4): 235–46.
8. Thomson CD. Selenium and iodine intakes and status in New Zealand and Australia. Br J Nutr 2004;91(05):661–72.
HEARTBEAT: Executive overcomes fears of major bleeds to start anticoagulant
1. The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Guidelines for the management of atrial fibrillation. Eur Heart J 2010;31:2369–429. Available online at http://eurheartj.oxfordjournals.org/content/31/19/2369
2. Connolly SJ, Ezekowitz MD, Yusuf S et al RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361(12):1139–51. Available online at http://www.nejm.org/doi/full/10.1056/NEJMoa0905561
OCCUPATIONAL HEALTH: A ‘she’ll be right’ approach to work safety is as Kiwi as pavlova
1. Royal Commission on the Pike River Coal Mine Tragedy. Volume 1 and
overview. Wellington: Royal Commission on the Pike River Coal
Mine Tragedy, 2012.
2. Independent Taskforce on workplace health and safety. The report of the Independent Taskforce on workplace health and safety, executive report. Wellington: Independent Taskforce on workplace health and safety, 2013.
3. Glover S, Brown N et al. Workplace health and safety culture change. Wellington: MartinJenkins and Associates, 2013.
4. Nielsen. Health and safety attitudes and behaviours in the New Zealand workforce: A survey of workers and employers. 2014 baseline survey. Cross-sector report. Wellington: Nielsen, 2015.
HOW TO TREAT: UTI in adults
1. eTG complete (www.tg.org.au). Melbourne: Therapeutic Guidelines Limited. Initial assessment and management of aged-care residents with suspected UTI.
https://www.tg.org.au/etg_demo/phone/abg15_figure9_uti_aged-care-facilities_flowchart.pdf
2. BPAC NZ. Antibiotics: choices for common infections. Supplement 2013. Available online at www.bpac.org.nz/antibiotics
3. Bratzler DW, Dellinger EP, Olsen KM et al [American Society of Health-System Pharmacists report]. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 2013;70:195–283.
4. Hooton TM, Roberts PL, Cox ME et al. Voided midstream urine culture and acute cystitis in premenopausal women. N Engl J Med 2013;369(20):1883–91.
5. Kupelian AS, Horsley H, Khasriya R et al. Discrediting microscopic pyuria and leucocyte esterase as diagnostic surrogates for infection in patients with lower urinary tract symptoms: results from a clinical and laboratory evaluation. BJU Int 2013;112(2):231–38.
6. Bleidorn J, Gágyor I, Kochen MM et al. Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for uncomplicated urinary tract infection? Results of a randomised controlled pilot trial. BMC Medicine 2010;8:30.
7. New Zealand Ministry of Health, ESR Public Health Surveillance. General antimicrobial susceptibility data: 2013 reports. Available online at https://surv.esr.cri.nz/antimicrobial/general_antimicrobial_susceptibility.php
8. Stalenhoef JE, van Dissel JT, van Nieuwkoop C. Febrile urinary tract infection in the emergency room. Curr Opin Infect Dis 2015;28:106–11.
9. Jepson RG, Williams G, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database of Systematic Reviews 2012, Issue 10. Art. No.: CD001321.
10. Kennedy K, Collingnon P. Colonisation with Escherichia coli resistant to “critically important” antibiotics: a high risk for international travellers. Eur J Clin Microbiol Infect Dis 2010 Dec;29(12):1501–6.
16 September 2015
Practice
CHILD HEALTH: HEEADSSS up on those awkward conversations with adolescents
1. Clark TC, Fleming T, Bullen P et al. Youth’12 overview: the health and wellbeing of New Zealand secondary school students in 2012. Auckland: The University of Auckland, 2013.
2. Klein DA, Goldenring JM, Adelman WP. HEEADSSS 3.0: the psychosocial interview for adolescents updated for a new century fueled by media. Contemporary Pediatrics 2014, Jan 17–28. Available online at http://bit.ly/1JuabA8
3. Hutchinson JW, Stafford EM. Changing parental opinions about teen privacy through education. Pediatrics 2005;116(4):966–71.
MEDICOLEGAL: Do the opinions of GPs carry any weight after hospital admission?
1. Health and Disability Commissioner opinion. Case 13 HDC01651
2. Health and Disability Commissioner. Decision 08HDC04311
2 September 2015
Practice
ELDER HEALTH: Polypharmacy - prescribing many drugs, or too many drugs?
1. Patterson SM, Cadogan CA, Kerse N et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database of Systematic Reviews 2014 (10). DOI: 10.1002/14651858.CD008165.pub3. Available online at http://www.cochranelibrary.com/enhanced/doi/10.1002/14651858.CD008165.pub3
2. Payne RA, Abel GA, Avery AJ et al. Is polypharmacy always hazardous? A retrospective cohort analysis using linked electronic health records from primary and secondary care. Br J Clin Pharmacol 2014;77:1073–82.
TRAVEL MEDICINE: Rabies pre-exposure immunisation needs greater attention
1. Bali Discovery Tours. Rabies in Bali. 8 March 2015. Available online at: https://www.balidiscovery.com/messages/message.asp?Id=12133 (Accessed 14 August 2015).
2. New Zealand Herald online: NZME. Dog bite statistics ‘horrific’, says father. 2 August 2015. Available online at www.nzherald.co.nz/nz/news/article.cfm?c_id=1&objectid=11490920 (Accessed 4 August 2015)
3. Shaw MTM, Visser J, Edwards C. Rabies postexposure consultations in New Zealand from 1998 to 2012. J Travel Med 2015;22(1):31-38. Available online at http://onlinelibrary.wiley.com/doi/10.1111/jtm.12167/full
4. Gautret P, Harvey K, Pandey P et al. Animal-associated exposure to rabies virus among travelers, 1997–2012. Emerg Infect Dis 2015;21(4):569–77.
19 August 2015
Practice
MEDICOLEGAL: Euthanasia - what the Seales case means for palliative care
1. Seales v Attorney-General [2015] New Zealand High Court 1239.
2. Seales v Attorney-General [2015] New Zealand High Court 1239.
Paragraph 99.
3. Airdale NHS Trust v Bland [1993] AC 789 (House of Lords).
4. Seales v Attorney-General [2015] New Zealand High Court 1239.
Paragraph 145.
5. Seales v Attorney-General [2015] New Zealand High Court 1239.
Paragraph 79.
6. Jansen-van der Weide MC, Onwuteaka-Philipsen BD, van der Wal G. Granted, undecided, withdrawn and refused requests for euthanasia and physician assisted suicide. Arch Intern Med 2005;165;1698–704.
7. Onwuteaka-Philipsen BD, van der Heide A, Koper D et al. Euthanasia and other end-of-life decisions in the Netherlands in 1990, 1995, and 2001. Lancet 2003;362:395–99.
8. Groenewoud JH, van der Heide A, Onwuteaka-Philipsen BD et al. Clinical problems with the performance of euthanasia and physician-assisted suicide in the Netherlands. N Engl J Med 2000;342(8):551–56.
SPORTS MEDICINE: Exercising for 30 minutes reduces hypertension for up to 24 hours
1. James PA, Oparil S, Carter BL et al. 2014 evidence-based guideline for the management of blood pressure in adults: report from the panel members appointed to the eighth Joint National Committee (JNC 8). J Am Med Assoc 2014;311(5):507–20. [Correction: J Am Med Assoc 2014:311(17):1809]
2. Eckel RH, Jakicic JM, Ard JD et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: A report of the ACC/AHA Task Force on Practice Guidelines. J Am Coll Cardiol 2014;63(25 Pt B):2960–84. [Correction: J Am Coll Cardiol 2014;63(25 Pt B):3027–28].
3. Pescatello LS, MacDonald HV, Ash GI et al. Assessing the existing professional exercise recommendations for hypertension: A review and recommendations for future research priorities. Mayo Clin Proc 2015;90(6):801-12.
5 August 2015
Practice
VACCINES: Immune-mediated inflammatory disease patients at special risk
1. Agarwal N, Ollington K, Kaneshiro M et al. Are immunosuppressive medications associated with decreased responses to routine immunizations? A systematic review. Vaccine 2012;30(8):1413–24.
2. Löbermann M, Boršo D, Hilgendorf I et al. Immunization in the adult immunocompromised host. Autoimmun Rev 2012;11(3):212–18.
3. Rahier J-F, Moutschen M, Van Gompel A et al. Vaccinations in patients with immune-mediated inflammatory diseases. Rheumatology 2010;49(10):1815–27.
4. van Assen S, Agmon-Levin N, Elkayam O et al. EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 2011;70(3):414–22.
5. Wotton CJ, Goldacre MJ. Risk of invasive pneumococcal disease in people admitted to hospital with selected immune-mediated diseases: Record linkage cohort analyses. J Epidemiol Community Health 2012;66(12):1177–81.
HEARTBEAT: Atrial fibrillation gives business heavyweight gym palpitations
1. Pathak RK Middeldorp ME, Meredith M et al. Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY). J Am Coll Cardiol 2015: 65: 2159–69.
22 July 2015
Practice
FROM THE LAB: Woman's unsteadiness due to her biochemical imbalance
1. Huang CL, Kuo E. Mechanism of hypokalemia in magnesium deficiency. J Am Soc Nephrol 2007;18(10):2649–52.
2. Marshall WJ, Bangert SK, Lapsley M. Clinical Chemistry (seventh edition). Mosby Ltd, 2012.
MEDICOLEGAL: Is caring for a family member or friend considered interference?
1. Gawande A. Being mortal: medicine and what matters in the end. London: Profile Books Ltd, October 2014.
2. Medical Council of New Zealand. Statement on providing care to yourself and those close to you. MCNZ, June 2013.
SEXUAL HEALTH: A worried patient asks about HPV and oropharyngeal cancer
1. Chaturvedi AK, Engels EA, Anderson WF et al. Incidence trends for human papillomavirus-related and unrelated squamous cell carcinomas in the United States. J Clin Oncol 2008;26:612–19.
2. Steinau M, Saraiya M, Goodman MT et al. Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States. Emerg Infect Dis 2014;20:822–28.
3. Gillison ML, Broutian T, Pickard RK et al. Prevalence of oral HPV infection in the United States, 2009-2010. J Am Med Assoc 2012;307:693–703.
4. Kreimer AR, Clifford GM, Boyle P et al. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005;14:467–75.
5. Chaturvedi AK, Engels EA, Pfeiffer RM et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011;29:4294–301.
6. Fakhry C, Westra WH, Li S et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008;100:261–69.
7. Heck JE, Berthiller J, Vaccarella S et al. Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. Int J Epidemiol 2010;39:166–81.
8. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010;363:24–35.
9. Gillison M, Zhang Q, Jordan R et al. Tobacco smoking and increased rate of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. J Clin Oncol 2012;30:2102–11.
10. Kreimer AR. Prospects for prevention of HPV-driven oropharynx cancer. Oral Oncol 2014;50:555–59.
11. Fakhry C, D'Souza G. Discussing the diagnosis of HPV-OSCC: common questions and answers. Oral Oncol 2013;49:863–71.
12. D'Souza G, Cullen K, Bowie J et al. Differences in oral sexual behaviors by gender, age, and race explain observed differences in prevalence of oral human papillomavirus infection. PLoS One 2014;9:e86023.
8 July 2015
Practice
ELDER HEALTH: Risk of falls in the elderly should allow for hours of activity
1. Klenk J, Kerse N, Rapp K et al, for the ActiFE Study Group. Physical activity and different concepts of fall risk estimation in older people – results of the ActiFE-Ulm Study. PLOSone 2015 Jun 9. DOI: 10.1371/journal.pone.0129098. Available online at http://bit.ly/1R73oAU
HEARTBEAT: Patient concerned at how his statin use raises arterial calcification
1. Puri R, Nicholls SJ, Shao M et al. Impact of statins on serial coronary calcification during atheroma progression and regression. J Am Coll Cardiol 2015;65:1273–82.
TRAVEL MEDICINE: Lest we forget: A pilgrimage to Gallipoli on the list for many
1. Ministry for Culture and Heritage. Gallipoli casualties by country. Available online at http://www.nzhistory.net.nz/media/interactive/gallipoli-casualties-country
2. Ministry for Culture and Heritage. The Gallipoli campaign –invasion. Available online at http://www.nzhistory.net.nz/war/the-gallipoli-campaign/landing-plans
3. Burton OE. The Silent Division: New Zealanders at the Front, 1914-1919. 1935
4. Burton OE, New Zealand Medical Corps, quoted in Gavin McLean, Ian McGibbon & Kynan Gentry. The Penguin Book of New Zealanders at War, 2009
24 June 2015
Practice
CHILD HEALTH: Reduce the pain and distress of vaccination? Yes, we can
1. World Health Organization. Report to SAGE on reducing pain and distress at the time of vaccination, 31 March 2015. Available online (pdf) at http://www.who.int/immunization/sage/meetings/2015/april/1_SAGE_latest_pain_guidelines_March_24_Final.pdf
2. Meeting of the Strategic Advisory Group of Experts on immunization, April 2015: conclusions and recommendations. Weekly Epidemiological Record 29 May 2015;90(22):261–80.
3. HELPinKIDS&Adults 2.0 Clinical Practice Guideline – summary and recommendations [submitted for publication in 2015]
4. Taddio A, Appleton M, Bortolussi R et al. Reducing the pain of childhood vaccination: an evidence-based clinical practice guideline. Can Med Assoc J 2010 Dec 14;182(18):E843–55.
10 June 2015
Practice
VACCINES: Shingles vaccine reduces disease severity and sequelae in elderly
1. Lui B, Heywood AE, Reekie J et al. Risk factors for herpes zoster in a large cohort of unvaccinated older adults: a prospective cohort study. Epidemiol Infect 2015. doi:10.1017/S0950268814003653
2. Johnson RW, Bouhassira D, Kassianos G et al. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Medicine 2010;8,37. doi:10.1186/1741-7015-8-37
3. Keating GM. Shingles (herpes zoster) vaccine (Zostavax): a review of its use in the prevention of herpes zoster and postherpetic neuralgia in adults aged ≥50 years. Drugs 2013;73:1227–44. doi: 10.1007/s40265-013-0088-1
4. Medsafe. New Zealand Data Sheet. Zostavax. Available online at http://www.medsafe.govt.nz/profs/Datasheet/z/zostavaxinj.pdf
5. Hales CM, Harpaz R, Ortega-Sanchez I et al. Update on recommendations for use of herpes zoster vaccine. MMWR 2014 August 22;63(33);729–31. Available online at http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6333a3.htm
6. Schmader KE, Oxman MN, Levin MJ et al. Persistence of the efficacy of zoster vaccine in the Shingles Prevention Study and the short-term persistence substudy. Clin Infect Dis 2012;55(10):1320–28. doi: 10.1093/cid/cis638
7. Morrison VA, Johnson GR, Schmader KE et al. Long-term persistence of zoster vaccine efficacy. Clin Infect Dis 2015 Mar 15;60(6):900–9.
8. Schmader KE, Levin,MJ, Gnann JW et al Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50–59 years. Clin Infect Dis 2012;54(7):922–28.
9. CDC. Update on herpes zoster vaccine: licensure for persons aged 50 through 59 years. MMRW 2011 November 11;60(44);1528. Available online at http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6044a5.htm
10. UK Government Department of Health. Millions more protected against disease through improved vaccination programme [press release]. 30 April 2013. Accessed May 2015. Available online at https://www.gov.uk/government/news/millions-more-protected-against-disease-through-improved-vaccination-programme
ELDER HEALTH: Food for thought on maintaining muscle mass as we age
1. Denison HJ, Cooper C, Aihie A et al. Prevention and optimal management of sarcopenia: a review of combined exercise and nutrition interventions to improve muscle outcomes in older people. Clin Interventions Aging 2015;10:859–69.
27 May 2015
Practice
CHILD HEALTH: NP’s case-management approach benefits children and youth
1. King J, Corter A, Brewerton R et al. Nurse practitioners in primary care: benefits for your practice, Australian General Practice Network, Auckland: Julian King & Associates Limited; Kinnect Group, 2012
FIRST TIME: The first time you log on to Twitter just remember 12 words
1. Pew Research Center. Social networking fact sheet. Available online at: http://www.pewinternet.org/fact-sheets/social-networking-fact-sheet/
2. Pew Research Center. Social networking fact sheet. Available online at: http://www.pewinternet.org/fact-sheets/social-networking-fact-sheet/
3. Facebook. Fans of the AVN community. Available online at: https://www.facebook.com/avn.living.wisdom
4. YouTube. Digital in healthcare – 2013 update. Available online at: https://www.youtube.com/watch?v=WnmCvj0mxYA
5. KevinMD.com. Twitter makes me a better doctor: 4 reasons why I use Twitter. Available online at: http://www.kevinmd.com/blog/2013/03/twitter-doctor-4-reasons-twitter.html
6. Royal College of General Practitioners. Social media highway code. Available online at: http://www.rcgp.org.uk/social-media
7. Mayo Clinic. A 12-word social media policy. Available online at: http://network.socialmedia.mayoclinic.org/discussion/a-12-word-social-media-policy/
8. Ko Awatea. How to use Twitter. Available online at: http://koawatea.co.nz/media/how-to-use-twitter/
MEDICOLEGAL: Clinical acumen of others little use if not called upon by juniors
1. 2015 International Forum on Quality and Safety in Healthcare. London, April 2015.
2. Office of the Health and Disability Commissioner. Opinion 08HDC043111
3. Newham R, Thomson AH, Semple Y et al. Barriers to the safe and effective use of intravenous gentamicin and vancomycin in Scottish Hospitals, and strategies for quality improvement. Eur J Hosp Pharm 2015;22:32–37.
13 May 2015
Practice
CHILD HEALTH: On-time scheduled vaccinations the best protection possible
1. Cameron GC, Turner NM, York DG et al. Factors associated with immunisation coverage and timeliness in New Zealand. Br J Gen Pract 2010;60(572):113–20.
2. Turner N. The challenge of improving immunisation coverage: the New Zealand example. Expert Rev Vacc 2012;11(1):9–11.
3. Andre FE. The suture of vaccine, immunisation concepts and practice. Vaccine 2001;19(17–19):2206–09.
4. Reid S. The further and future evolution of the New Zealand Immunisation
Schedule. N Z Med J 2012;125(1354):86–99.
5. Grant CC, Reid S. Pertussis continues to put New Zealand’s immunisation strategy to the test. J N Z Med Assoc 2010;123(1313):46–61.
6. Ministry of Health. Immunisation coverage at milestone age (24 months of age) report; report period: 12 month period ending September 2014. Wellington: Ministry of Health, 2014.
7. Somerville RL, Grant CC, Scragg RK et al. Hospitalisations due to pertussis in New Zealand in the pre-immunisation and mass immunisation eras. J Paediatr Child Health 2007;43(3):147–53.
8. Petousis-Harris H, Grant CC, Goodyear-Smith F et al. What contributes to delays? The primary care determinants of immunisation timeliness in New Zealand. J Prim Care 2011;4(1):12–20.
9. Crowcroft NS, Stein C, Duclos P et al. How best to estimate the global burden of pertussis? Lancet Infect Dis 2003 Jul;3(7):413–18.
10. Goodyear-Smith F, Grant C, Poole T et al. Early connections: effectiveness of a pre-call intervention to improve immunisation coverage and timeliness. J Prim Care 2012;4(3):189–98.
11. Wroe AL, Turner N, Salkovskis PM. Understanding and predicting parental decisions about early childhood immunisations. Health Psych 2004;23(1):33–41.
12. Ministry of Health. Enrolling babies at birth: a resource for general practice.
Wellington: Ministry of Health, 2014.
ELDER HEALTH: For elderly reminiscence and nostalgia more than sentiment
1. Wildschut T, Sedikides C, Arndt J et al. Nostalgia: content, triggers, functions. J Personality Soc Psych 2006;91(5):975–93.
2. Bohlmeijer E, Roemer M, Cuijpers P et al. The effects of reminiscence on psychological well-being in older adults: a meta-analysis. Aging Mental Health 2007;11:291–300.
3. Forsman AK, Schierenbeck I, Wahlbeck K. Psychosocial interventions for the prevention of depression in older adults: systematic review and meta-analysis. J Aging Health 2011;23:387–416.
29 April 2015
Practice
FIRST TIME: It is easy to create negative expectations: The nocebo effect
1. BBC Radio 4. The placebo problem. Available to listen online at http://www.bbc.co.uk/programmes/b052j0ty
2. Faasse K, Cundy T, Petrie K. Thyroxine: anatomy of a health scare [observations]. BMJ 2 Jan 2010; 340: 20–21. Available online at https://www.fmhs.auckland.ac.nz/assets/fmhs/som/psychmed/petrie/docs/2010%20thyroxine%20bmj.pdf
MEDICOLEGAL: Consent is now patient centric in the UK, as it is in New Zealand
1. Montgomery v Lanarkshire Health Board (Respondent). UK Supreme Court, 11 March 2015. UKSC 11.
2. Sokol DK. Update on the UK law on consent. BMJ 2015;350:h1481.
3. Hutson MM, Blaha JD. Patient recall of preoperative instruction for informed consent for an operation. J Bone Joint Surg Am 1991 Feb;73(2):160–2.
4. Taylor EM, Ramsay MP, Bunton L. Do our patients understand? A comparison of understanding in adult inpatients and school children. N Z Med J 1998 Nov 27;111(1078):449–51.
5. Taylor EM, Ramsey MP, Bunton L. Do our patients understand? A comparison of understanding in adult inpatients and school children. N Z Med J 1998 Nov 27;449.
6. Gillick v West Norfolk and Wesbech Area Health Authority [1985] 3 All ER 402.
7. New Zealand Government. Care of Children Act, 2004. Section 38.
8. Peters C. Consenting to medical treatment: legal requirements vs medical practice. Are healthcare providers exposing themselves to potential legal action? N Z Med J 2009 Aug 7;122:50–59.
9. Harman v Director of Proceedings, High Court Auckland, CIV-2007-404-003732, 12 March 2009.
10. Rogers v Whittaker (1992) 175 CLR479 (Australian High Court decision) and New Zealand Patient Code of Rights, right 6: “Every consumer has the right to the information that a reasonable consumer, in that consumer’s circumstances, would expect to receive.”
11. Kirk P, Kirk I, Kristjanson LJ. What do patients receiving palliative care for cancer and their families want to be told? A Canadian and Australian qualitative study. BMJ 2004;328:1343.
15 April 2015
Practice
CHILD HEALTH: Influenza awareness campaign 2015 takes on a new look
1. Schanzer DL, Langley JM, Tam TWS. Influenza-attributed hospitalization rates among pregnant women in Canada 1994–2000. J Obstet Gynaecol Can 2007;29(8):622–9.
OCCUPATIONAL HEALTH: A swinging door, a shoulder injury and a slow recovery
1. Accident Compensation Corporation. Distal upper limb: guidelines for management of some common musculoskeletal disorders. Wellington: Accident Compensation Corporation, 2009. Available online at http://www.acc.co.nz/PRD_EXT_CSMP/groups/external_communications/documents/guide/wcm001684.pdf Accessed 16 March 2015.
2. Buchbinder R, Green S, Youd JM. Corticosteroid injections for shoulder pain. Cochrane database of systematic reviews, 2003. Available online at http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD004016/abstract Accessed 16 March 2015.
3. Green S, Buchbinder R, Hetrick S. Physiotherapy interventions for shoulder pain. Cochrane database of systematic reviews, 2003. Available online at http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD004258/abstract Accessed 16 March 2015.
4. Coghlan JA, Buchbinder R, Green S et al. Surgery for rotator cuff disease. Cochrane database of systematic reviews, 2008. Available online at http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD005619.pub2/abstract Accessed 16 March 2015.
18 March 2015
Newsletters
The science of uncertainty: Decision strategies in complex system of health
References
1.Snowden D. Strategy in the context of uncertainty.Handbook of Business Strategy2005;6(1):47–54.
2.McLeod J., Childs S. The Cynefin framework: A tool for analyzing qualitative data in information science?Library and Information Science Research2013;35(4):299–309.
3.Snowden D.J., Boone M.E. A leader's framework for decision making. A leader's framework for decision making.Harv Bus Rev2007;85(11):68.
4.Schloss E.P. A dynamic framework for planning under simple, complicated, and complex conditions.Emergence: Complexity and Organization2014;16(2):93.
Practice
CHILD HEALTH: RotaTeq and intussusception: Adequate post-immunisation advice
1. Monk HM, Motsney AJ Wade KC. Safety of rotavirus vaccine in the NICU. Pediatrics 2014;133:6 e1555-e1560.
2. Carlin JB, Macartney KK, Lee KJ et al. Intussusception risk and disease prevention associated with rotavirus vaccines in Australia’s National Immunization Program. Clin Infect Dis 2013;57(10):1427–34.
3. Macartney KK, Porwal M, Dalton D et al. Decline in rotavirus hospitalisations following introduction of Australia’s national rotavirus immunisation programme. J Paediatr Child Health 2011;47:266–70.
4. Merck Sharp & Dohme (New Zealand) Limited. RotaTeq. 3 July 2013. Available online at www.medsafe.govt.nz/profs/datasheet/r/RotaTeqsusp.pdf (accessed 7 Feb 2015).
5. Clark HF, Offit PA, Parashar UD. Rotavirus vaccines In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines: expert consult, 6th ed. Elsevier Saunders, 2013.
CLINICAL UPDATE: Severe infection in primary care: A refresher on early recognition
1. Lala HM, Mills GD, Barratt K et al. Meningococcal disease deaths and the frequency of antibiotic administration delays. J Infect 2007;54:551–57.
2. BPAC New Zealand. Antibiotics: choices for common infections. Supplement, 2013. Available online at www.bpac.org.nz/antibiotics
3. Barquet N, Domingo P, Caylà JA et al. Prognostic factors in meningococcal disease: development of a bedside predictive model and scoring system. JAMA 1997;278:491–96.
4. Brent AJ, Lakhanpaul M, Thompson M et al. Risk score to stratify children with suspected serious bacterial infection: observational cohort study. Arch Dis Child 2011;96:361–67.
5. Lee CC, Wu CJ, Chi CH et al. Prediction of community-onset bacteraemia among febrile adults visiting an emergency department: rigor matters. Diagn Microbiol Infect Dis 2012;73(2):168–73.
6. Sanders S, Barnett A, Correa-Velez I et al. Systemic review of the diagnostic accuracy of C-reactive protein to detect bacterial infection in non-hospitalized infants and children with fever. J Pediatr 2008;153:570–74.
7. Van Vugt S, Broekhuizen BDL, Lammens C et al. Use of serum C reactive protein and procalcitonin concentrations in addition to symptoms and signs to predict pneumonia in patients presenting to primary care with acute cough: diagnostic study. BMJ 2013; 346:f2450
ELDER HEALTH: Falls programme for 2015 to focus on primary care
1. Swift CG, Iliffe S. Assessment and prevention of falls in older people - concise guidance. Clin Med 2014;14(6):658–62.
2. Cameron I D, Gillespie LD, Robertson CM et al. Interventions for preventing falls in older people in care facilities and hospitals. Cochrane Database of Systematic Reviews (3), 2013.
3. Gillespie LD, Robertson CM, Gillespie WJ et al. Interventions for preventing falls in older people living in the community. Cochrane Database of Systematic Reviews (11), 2012.
TRAVEL MEDICINE: South Pacific travel demands greater focus on arboviral disease
1. The global impact of dengue fever. Available at: www.who.int/csr/disease/dengue/impact/en/ (accessed 14 Feb, 2015)
2. Chikungunya could spread to Pacific nations that have not experienced the virus. Available at: www.radioaustralia.net.au/international/2015-01-14/chikungunya-could-spread-to-pacific-nations-that-have-not-experienced-the-virus-health-officials-say/1406429 Accessed 16 Feb, 2015)
3. Chikungunya. Available at: www.who.int/denguecontrol/arbo-viral/other_arboviral_chikungunya/en/ (accessed 18 Feb, 2015)
4. Zika Virus Infection Complicated by Guillain-Barré Syndrome – Case Report, French Polynesia, December 2013. Available at: www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20720 (Accessed 18 Feb, 2015)
5. Shaw MTM. Insect-borne diseases and insect bite protection. In: Travel Medicine Guide, 7th Edition. Auckland: MIMS New Zealand, 2013: 36-43.
4 March 2015
Practice
FIRST TIME: The first time dealing with an ingrown toenail
1. Eekhof JAH, VanWijk B, Knuistingh Neven A et al. Interventions for ingrowing toenails (review). Cochrane Database of Systematic Reviews 2012, Issue 4. Art. No.: CD001541. DOI: 10.1002/14651858.CD001541.pub3. Available online at http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD001541.pub3/pdf
2. BPAC. Ingrown toenails: digging out the facts. Best Pract J 2014; 65. Available online at http://www.bpac.org.nz/BPJ/2014/December/ingrown-toenails.aspx
FROM THE LAB: New biomarkers aid treatment plan in persistent dyslipidaemia
1. d’Emden MC, Jenkins AJ, Li L et al. Favourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia 2014;57(11):2296–303.
MEDICOLEGAL: Information requests: avoid siding with either Montagues or Capulets
1. New Zealand Government. Section 22F of the Health Act 1956.
2. New Zealand Government. Section 29(1) of the Privacy Act 1993.
3. Privacy Commissioner. Case Note 9603 [1998] NZPrivCmr 14- Hospital refuses parents access to estranged daughter's medical report. Available online at https://privacy.org.nz/news-and-publications/case-notes-and-court-decisions/case-note-9603-1998-nzprivcmr-14-hospital-refuses-parents-access-to-estranged-daughter-s-medical-report/
18 February 2015
Practice
VACCINES: SAGE advice informs global targets and programmes for immunisation
1. World Health Organization. Meeting of the Strategic Advisory Group of Experts on Immunization, October 2014 – conclusions and recommendations. Weekly epidemiological record, 2014 [internet];50(89):561–76. Epub 12 December 2014. Available online at http://www.who.int/wer
2. World Health Organization. SAGE meeting of October 2014: immunization, vaccines and biologicals, 2014 [cited 5 January 2105]. Available online at http://www.who.int/immunization/sage/meetings/2014/october/en/
3. World Health Organization. Global Vaccine Action Plan 2011–2020 [cited 5 January 2015]. Available online at http://www.who.int/immunization/global_vaccine_action_plan/GVAP_doc_2011_2020/en/
4. World Health Organization. Global Vaccine Action Plan: report by the secretariat, 2014 [internet]. Available online at http://apps.who.int/gb/ebwha/pdf_files/EB136/B136_25-en.pdf
ELDER HEALTH: Pruning prescribing habits for the elderly might be appropriate
1. Chieng JHC, Hughes L, Stewart A et al. Introduction of the Pill Pruner to acute medical care: a simple medication guide to control polypharmacy. Aust J Ageing 2015. Article first published online 12 Jan 2015. DOI:10.1111/ajag.12183
OCCUPATIONAL HEALTH: Tasers shown more often than deployed, but risks remain
1. Owen A. When tuppence bought the world. Spectrum 11 January 2015. Available online as a podcast at Radio New Zealand http://www.radionz.co.nz/national/programmes/spectrum/20150111
2. Becour B. Conducted electrical weapons or stun guns: a review of 46 cases examined in casualty. Am J For Med Pathol 2013;34:142–46.
3. Zipes D. Sudden cardiac arrest and death following application of shocks from a Taser electronic control device. Circulation 2012;125:2417–22.
4 February 2015
Practice
FIRST TIME: Call the doctor the first time you get sick
1. Bracewell LM, Campbell DI, Faure PR et al. Sickness presenteeism in a New Zealand hospital. N Z Med J 2010; 123: 1314. Available online at https://www.nzma.org.nz/journal/read-the-journal/all-issues/2010-2019/2010/vol-123-no-1314/article-bracewell
2. Bird S. Doctors as patients. Aust Fam Physician 2008;37(4):256–57.
3. Kay M, Mitchell G, Clavarino A et al. Doctors as patients: a systematic review of doctors’ health access and barriers they experience. Br J Gen Pract 2008 Jul 1;58:501–08.
4. Doctors’ Health Advisory Service. Available online at http://www.dhas.org.au/table/contact/
CHILD HEALTH: Children at risk through disability or ethnicity have specific rights
1. UNICEF. Fact sheet: a summary of the rights under the Convention
on the Rights of the Child. Available online at www.unicef.org/crc/files/Rights_overview.pdf
SEXUAL HEALTH: Non-albicans and azole-resistant C. albicans vulvovaginal candidiasis
1. Centers for Disease Control and Prevention. Antibiotic/antimicrobial resistance: threat report 2013. Section 3: Current Antibiotic Resistance Threats in the United States, by Microorganism. Available online at http://www.cdc.gov/drugresistance/threat-report-2013/
2. World Health Organization. Antimicrobial resistance: global report on surveillance, 2014. Available online at http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748_eng.pdf
3. Arendrup MC. Update on antifungal resistance in Aspergillus and Candida. Clin Microbiol Infect 2014;20(Suppl 6):42–48.
4. Ashbee HR, Barnes RA, Johnson EM et al. Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology. J Antimicrob Chemother 2014;69:1162–76.
5. Pilmis B, Jullien V, Sobel J et al. Antifungal drugs during pregnancy: an updated review. J Antimicrob Chemother doi:10.1093/jac/dku355 (Advance access; published 8 September 2014).
6. Rosa MI, Silva BR, Pires PS et al. Weekly fluconazole therapy for recurrent vulvovaginal candidiasis: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 2013;167(2):132–36.
7. Davies S, Johnson E, White D. How to treat persistent vaginal yeast infection due to species other than Candida albicans. Sex Transm Infect 2013;89:165–66.
MEDICOLEGAL: Being human in the professional sphere: Thoughts for 2015
1. Gawande A. Better: a surgeon’s notes on performance. London: Profile Books Ltd, 2007.
2. Health and disability commissioner. Decision 12HDC00203, 21 June 2013.
CLINICAL UPDATE: Men suffer one in three of all osteoporotic fractures
1. Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 2006;17:1726–33.
2. Nguyen ND, Ahlborg HG, Center JR et al. Residual lifetime risk of fractures in women and men. J Bone Miner Res 2007;22:781–88.
3. von Friesendorff M, McGuigan FE, Besjakov J et al. Hip fracture in men-survival and subsequent fractures: a cohort study with 22-year follow-up. J Am Geriatr Soc 2011;59:806–13.
4. Feldstein AC, Nichols G, Orwoll E et al. The near absence of osteoporosis treatment in older men with fractures. Osteoporos Int 2005;16:953–62.
5. Szulc P, Delmas PD. Biochemical markers of bone turnover in men. Calcif Tissue Int 2001;69:229–34.
6. Jones G, Nguyen T, Sambrook P et al. Progressive loss of bone in the femoral neck in elderly people: longitudinal findings from the Dubbo osteoporosis epidemiology study. BMJ 1994;309:691–95.
7. Papaioannou A, Kennedy CC, Cranney A et al. Risk factors for low BMD in healthy men age 50 years or older: a systematic review. Osteoporos Int 2009;20:507–18.
8. Seeman E, Bianchi G, Khosla S et al. Bone fragility in men – where are we? Osteoporos Int 2006;17:1577–83.
9. Ebeling PR. Osteoporosis in men. Curr Opin Rheumatol 2013;25:542–52.
10. Watts NB, Adler RA, Bilezikian JP et al. Osteoporosis in men: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2012;97:1802–22.
11. 2013 ISCD Official Positions - Adult. 2013. Available online at http://www.iscd.org/official-positions/2013-iscd-official-positions-adult/ (Accessed 19 October, 2014).
12. Hofbauer LC, Hamann C, Ebeling PR. Approach to the patient with secondary osteoporosis. Eur J Endocrinol 2010;162:1009–20.
13. Ebeling PR. Clinical practice. Osteoporosis in men. N Engl J Med 2008;358:1474–82.
14. Kanis JA, Johnell O, Oden A et al. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 2008;19:385–97.
15. van Geel TA, Eisman JA, Geusens PP et al. The utility of absolute risk prediction using FRAX(R) and Garvan Fracture Risk Calculator in daily practice. Maturitas 2014;77:174–79.
16. Boonen S, Orwoll ES, Wenderoth D et al. Once-weekly risedronate in men with osteoporosis: results of a 2-year, placebo-controlled, double-blind, multicenter study. J Bone Miner Res 2009;24:719–25.
17. Orwoll E, Ettinger M, Weiss S et al. Alendronate for the treatment of osteoporosis in men. N Engl J Med 2000;343:604–10.
18. Orwoll ES, Binkley NC, Lewiecki EM et al. Efficacy and safety of monthly ibandronate in men with low bone density. Bone 2010;46:970-76.
19. Boonen S, Reginster JY, Kaufman JM et al. Fracture risk and zoledronic acid therapy in men with osteoporosis. N Engl J Med 2012;367:1714–23.
20. Lyles KW, Colon-Emeric CS, Magaziner JS et al. Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 2007;357:1799–809.
21. Lespessailles E. Bisphosphonates and glucocorticoid-induced osteoporosis: efficacy and tolerability. Joint Bone Spine 2013;80:258–64.
22. Greenspan SL, Nelson JB, Trump DL et al. Effect of once-weekly oral alendronate on bone loss in men receiving androgen deprivation therapy for prostate cancer: a randomized trial. Ann Intern Med 2007;146:416–24.
23. Smith MR, Eastham J, Gleason DM et al. Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer. J Urol 2003;169:2008–12.
24. Compston J. Pathophysiology of atypical femoral fractures and osteonecrosis of the jaw. Osteoporos Int 2011;22:2951–61.
25. Orwoll ES, Scheele WH, Paul S et al. The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis. J Bone Miner Res 2003;18:9–17.
26. Subbiah V, Madsen VS, Raymond AK et al. Of mice and men: divergent risks of teriparatide-induced osteosarcoma. Osteoporos Int 2010;21:1041–45.
27. Smith MR, Egerdie B, Hernandez Toriz N et al. Denosumab in men receiving androgen-deprivation therapy for prostate cancer. N Engl J Med 2009;361:745–55.
28. Orwoll E, Teglbjaerg CS, Langdahl BL et al. A randomized, placebo-controlled study of the effects of denosumab for the treatment of men with low bone mineral density. J Clin Endocrinol Metab 2012;97:3161–69.
29. Okada N, Kawazoe K, Teraoka K et al. Identification of the risk factors associated with hypocalcemia induced by denosumab. Biol Pharm Bull 2013;36:1622–26.
30. Papapoulos S, Chapurlat R, Libanati C et al. Five years of denosumab exposure in women with postmenopausal osteoporosis: results from the first two years of the FREEDOM extension. J Bone Miner Res 2012;27:694–701.
31. Kaufman JM, Audran M, Bianchi G et al. Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men. J Clin Endocrinol Metab 2013;98:592–601.
32. Hiligsmann M, Ben Sedrine W, Bruyere O et al. Cost-effectiveness of strontium ranelate in the treatment of male osteoporosis. Osteoporos Int 2013;24:2291–300.
33. Bolland MJ, Grey A. A comparison of adverse event and fracture efficacy data for strontium ranelate in regulatory documents and the publication record. BMJ Open 2014;4:e005787.
34. Aminorroaya A, Kelleher S, Conway AJ et al. Adequacy of androgen replacement influences bone density response to testosterone in androgen-deficient men. Eur J Endocrinol 2005;152:881–86.
35. Basurto L, Zarate A, Gomez R et al. Effect of testosterone therapy on lumbar spine and hip mineral density in elderly men. Aging Male 2008;11:140–45.
36. Bhasin S, Cunningham GR, Hayes FJ et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010;95:2536–59.
37. Basaria S, Coviello AD, Travison TG et al. Adverse events associated with testosterone administration. N Engl J Med 2010;363:109–22.
38. Grossman JM, Gordon R, Ranganath VK et al. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken) 2010;62:1515–26.
2014
17 December 2014
Practice
ELDER HEALTH: Find time for your elderly patients this Christmas, they may surprise
1. Teh R, Kerse N, Kepa M et al. Self-rated health, health-related behaviours and medical conditions of Maori and non-Maori in advanced age: LiLACS NZ. N Z Med J 2014;127(1397):13–29.
2. Dyall L, Kepa M, Teh R et al. Cultural and social factors and quality of life of Maori in advanced age. Te puawaitanga o nga tapuwae kia ora tonu - life and living in advanced age: a cohort study in New Zealand (LiLACS NZ). N Z Med J 2014;127(1393):62–79.
3. Dyall L, Kepa M, Hayman K et al. Engagement and recruitment of Maori and non-Maori people of advanced age to LiLACS NZ. Aust N Z J Publ Health 2013 Apr;37(2):124–31.
4. Hayman K, Kerse N, Dyall L et al. Life and Living in Advanced age: a Cohort Study in New Zealand, Te Puāwaitanga O Nga Tapuwae Kia ora Tonu: LILACS NZ, study protocol. BMC Geriatr 2012;12:33.
3 December 2014
Practice
CHILD HEALTH: Access to primary care is a child's right says UN, but barriers may exist
1. United Nations Human Rights Convention on the Rights of the Child. Available online at http://www.ohchr.org/EN/ProfessionalInterest/Pages/CRC.aspx
2. UNICEF. Children of the recession: the impact of the economic crisis on child well-being in rich countries. Innocenti Report Card 12. Florence: UNICEF, 2014.
3. Ministry of Health. Zero fees for under 6s. 2014. Available online at http://www.health.govt.nz/our-work/primary-health-care/primary-health-care-subsidies-and-services/zero-fees-under-6s
4. Ministry of Health. Newborn enrolment with general practices. Wellington: MOH, 2014. Available online at http://www.health.govt.nz/our-work/primary-health-care/primary-health-care-subsidies-and-services/newborn-enrolment-general-practices
5. Hoare KJ. Children’s participation in society is likely to lead to their improved health and wellbeing [Editorial]. N Z Med J 2014;127(1405).
6. Dickinson A, Wrapson W, Water T. Children’s voices in public hospital healthcare delivery: intention as opposed to practice. N Z Med J 2014;127(1405).
FIRST TIME: An eczema 'set piece' lets your practice speak with one voice
1. Eczema Clinical Network. Clinical network for the treatment of childhood eczema. Available online (pdf) at http://bit.ly/1B4QyQQ
MEDICOLEGAL: Try to exclude worst-case scenarios: You may avoid one of your own
1. Health and disability commissioner. Case 12HDC01291
2. Gawande A. The checklist manifesto: how to get things right. New York: Metropolitan Books, Henry Holt & Co, 2009.
3. Fox R. Essays in medical sociology: journeys into the field. New Brunswick: John Wylie & Sons, 1979.
SEXUAL HEALTH: Antibiotic-resistant STIs: The chief culprit is Neisseria gonorrhoeae
1. World Health Organization, Department of Reproductive Health and Research. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. WHO, 2012. Available online at http://www.who.int/reproductivehealth/publications/rtis/9789241503501/en/
2. ESR. Sexually transmitted infections in New Zealand 2013: surveillance report. ESR, June 2014. Available online at https://surv.esr.cri.nz/PDF_surveillance/STISurvRpt/2013/2013AnnualSTIReportFINAL.pdf
3. Lewis DA, Lukehart SA. Antimicrobial resistance in Neisseria gonorrhoeae and Treponema pallidum: evolution, therapeutic challenges and the need to strengthen global surveillance. Sex Transm Infect 2011;87:ii39–ii43 doi:10.1136/sti.2010.047712. Available online at http://sti.bmj.com/content/87/Suppl_2/ii39.full
4. Gonorrhoea Guideline Writing Group on behalf of the New Zealand Sexual Health Society. New Zealand guideline for the management of gonorrhoea, 2014, and response to the threat of antimicrobial resistance. NZSHS, Sep 2014 Available online at http://www.nzshs.org/guidelines/NZ-gonorrhoea-guideline-version-2014-09-10.pdf
SPORTS MEDICINE: Sports organisers need a rehearsed plan for sudden cardiac arrest
1. Drezner JA, Toresdahl BG, Rao AL et al. Outcomes from sudden cardiac arrest in US high schools: a 2-year prospective study from the National Registry for AED Use in Sports. Br J Sports Med 2013 Dec;47(18):1179–83.
19 November 2014
Practice
ELDER HEALTH: Elderly have excess risk of delirium and cognitive decline after surgery
1. Hussain M, Berger M, Eckenhoff RG et al. General anesthetic and the risk of dementia in elderly patients: current insights. Clin Interv Aging 2014 Sep 24; 9:1619–28.
OCCUPATIONAL HEALTH: Welding generates toxicants of the lung and other body systems
1. Antonini JM. Health effects of welding. Crit Rev Toxicol 2003;33(1):61–103.
2. Palmer KT, Cosgrove M. Vaccinating welders against pneumonia. Occup Med (Lond) 2012; 62(5):325–30. Available online at http://occmed.oxfordjournals.org/content/62/5/325.short
5 November 2014
Practice
CHILD HEALTH: Primary care assessment of chest pain in children: Is it cardiac?
1. Danduran MJ, Earing MG, Sheridan DC et al. Chest pain: characteristics of children/adolescents. Pediatr Cardiol 2008;29:775–81.
2. Drossner DM, Hirsh D, Sturm JJ et al. Cardiac disease in pediatric patients presenting to a pediatric ED with chest pain. Am J Emerg Med 2011;29:632–38.
3. Saleeb SF, Li WYV, Warren SZ et al. Effectiveness of screening for life-threatening chest pain in children. Pediatrics 2011;128: e1062–68.
4. Pantell RH, Goodman BW, Goodman W. Adolescent chest pain: a prospective study. Pediatrics 1983;71:881–87.
5. Collins SA, Gritsaitis, MJ, Legg JP. 15 minute consultation: a structured approach to the assessment of chest pain in children. Arch Dis Child Educ Pract Ed 2014;99:122–26.
DERMATOLOGY: Pathology request forms need to convey what you find and what you suspect
1. Rademaker M, Thorburn M. Pathology referrals for skin lesions—are we giving the pathologist sufficient clinical information? N Z Med J 5 November 2010;123:1325.
FIRST TIME: Recalls, results and referrals: Three Rs that bring responsibility
1. New Zealand Reader’s Digest. New Zealand’s most trusted professions 2012. Available online at http://www.readersdigest.co.nz/new-zealands-most-trusted-professions-2012
2. Health & Disability Commissioner. Website http://www.hdc.org.nz/
3. Medical Council of New Zealand. Statement on safe practice in an environment of resource limitation. MCNZ, August 2008. Available online at https://www.mcnz.org.nz/assets/News-and-Publications/Statements/Safe-practice-in-an-environment-of-resource-limitation.pdf
4. Medical Council of New Zealand. Good medical practice. MCNZ, April 2013. Available online at https://www.mcnz.org.nz/assets/News-and-Publications/good-medical-practice.pdf
SEXUAL HEALTH: Taking sexual histories in the techno-sexual era
1. O'Sullivan, LF. Linking online sexual activities to health outcomes among teens. New Dir Child Adolesc Dev 2014;144:37–51.
2. Clark TC. Youth’12 overview: the health and wellbeing of New Zealand secondary school students in 2012. Auckland: University of Auckland, 2013.
3. Bagshaw S. HEADSS and sexual health in primary care settings. SYPHANZ clinical skills day, 2011. Available online at http://syhpanz.co.nz/uploads/editor/files/HEEADSS-and-sexual-health-in-Primary-Care-Settings1.ppt
22 October 2014
Practice
CHILD HEALTH: Vaccines for the whole of life: private market vaccines in NZ
1. IMAC. Factsheet for professionals – private purchase of non-funded vaccines. 2014. Available online from http://bit.ly/1vsHRcc
2. Turner N, Petousis-Harris H, Batty K. Private market vaccines in New Zealand – an update. Research Review Educational Series [Internet]. 2012 [cited 25 Sep 2014]. Available online from http://bit.ly/1wVwaMb
3. Taylor L, Petousis-Harris H, Poole T et al. 2012 Antigen review for the New Zealand National Immunisation Schedule: varicella-zoster virus. [Internet] Auckland: University of Auckland, 2013 [cited 25 Sep 2014]. Available online from http://bit.ly/ZpaWvj
4. Pytynia KB, Dahlstrom KR, Sturgis EM. Epidemiology of HPV-associated oropharyngeal cancer. Oral Oncol 2014;50(5):380–86.
5. Petousis-Harris H, Turner N, Heffernan H et al. 2012 Antigen review for the New Zealand National Immunisation Schedule: pneumococcal. [Internet] Auckland University of Auckland, 2013 [cited Sep 2014]. Available online from http://bit.ly/1vuLAYN
6. Joura EA, Garland SM, Paavonen J et al. Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data. BMJ (Clin Res Ed) 2012;344:e1401.
7. Forbes HJ, Bhaskaran K, Thomas SL et al. Quantification of risk factors for herpes zoster: population based case-control study. BMJ (Clin Res Ed) 2014;348:g2911.
8. Amirthalingam G, Andrews N, Campbell H et al. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet 2014 Jul 15 [ePub ahead of print] doi: 10.1016/S0140-6736(14)60686-3.
TRAVEL MEDICINE: Travelling with children: horror story or happy campers?
1. Fischer P. Travel with infants and children. Infect Dis Clin N Am 1998;12(2):355–68.
2. Barnett ED. Immunizations and infectious disease screening for internationally adopted children. Pediatr Clin N Am 2005; 52(5):1287–309.
3. Hagmann S, Neugebauer R, Schwartz E et al. Illness in children after international travel: analysis from the GeoSentinel surveillance network. Pediatrics 2010;125(5):e1072–80 (doi: 10.1542/peds.2009-1951)
4. van Rijn SF, Driessen G, Overbosch D et al. Travel-related morbidity in children: a prospective observational study. J Travel Med 2012;19(3):144–49.
5. Neumann K. KidsTravelDoc.com. Available online at http://kidstraveldoc.com/wordpress/10-tips-air-travelsedating-infantsright-or-wrong/
6. Summer AP, Fischer PR. Pediatric, neonatal, and adolescent travelers. In: Keystone JS, Kozarsky PE, Freedman DO et al. (eds). Travel medicine. 2nd edition. Philedelphia: Mosby/Elsevier, 2009: pp223–33.
8 October 2014
Practice
CHILD HEALTH: General practice must enact UN treaty on children's rights
1. Action for Children and Youth Aotearoa. Rights of the Child. Available online at http://www.acya.org.nz/
2. Family Violence Death Review Committee, 2014. Fourth Annual Report: January 2013–December 2013. Wellington: Family Violence Death Review Committee.
3. Rankin D. Detecting child abuse in general practice. Best Pract J 2011; 38.
MEDICOLEGAL: Being part of the solution: a call to practitioners
1. Medical Council of New Zealand Annual Report for 1994.
2. Medical Council of New Zealand Annual Report for 2013.
3. Coney S, Bunkle P. An unfortunate experiment. Metro 1987, June.
4. Health Practitioners Disciplinary Tribunal, Decision 623 Nur 13/256P.
5. Roberts v A. Professional Conduct Committee of the Nursing Council of New Zealand [2012] NZHC 3354.
6. Colquhoun G. Foreword. In: Wilson H, Cunningham W. Being a doctor: understanding medical practice. Otago University Press, 2013. ISBN 978-1-877578-36-6
SPORTS MEDICINE: Vitamin D deficiency a common problem in athletes worldwide
1. Hamilton B. Vitamin D and skeletal muscle. Scand J Med Sci Sports 2010;20(2):182–90.
2. Bolland MJ, Grey A, Gamble GD et al. The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet (Diabet Endocrinol) 2014;2(4):307–20. Available online at http://dx.doi.org/10.1016/S2213-8587(13)70212-2
3. Allison RJ, Close GL, Farooq A et al. Severely vitamin D-deficient athletes present smaller hearts than sufficient athletes. Eur J Prev Cardiol 2014. Advance publication online, 7 January 2014. DOI:10.1177/2047487313518473.
4. Lappe J, Cullen D, Haynatzki G et al. Calcium and vitamin D supplementation decreases incidence of stress fractures in female navy recruits. J Bone Miner Res 2008;23(5):741–49.
5. Allison RJ et al., No association between vitamin D deficiency and markers of bone health in athletes. Med Sci Sport Exerc (to be published, 2014).
6. Powe CE, Evans MK, Wenger J et al. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med 2013;369(21):1991–2000.
24 September 2014
Practice
ELDER HEALTH: Different views cause friction when care is cross-cultural
1. Sevenhuijsen, SRL. Citizenship and the ethics of care: feminist considerations on justice, morality and politics. London: Routledge, 1998. (p137)
2. Kiata L, Kerse N. Working with the aged: lessons from residential care. In: Cultural safety in Aotearoa New Zealand. Dianne Wepa (ed). Auckland: Pearson Education New Zealand, 2005.
27 August 2014
Practice
HEARTBEAT: Statin-induced fears of an anxious patient
1. Sattar N, Preiss D, Murray HM et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet 2010;375:735–42.
2. Baigent C, Blackwell L, Emberson J et al for the Cholesterol Treatment Trialists’ (CTT) Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010;376:1670–81.
TRAVEL MEDICINE: Ebola has moved to the city: what do we do?
1. World Health Organization. WHO Director-General assesses the Ebola outbreak with three West African presidents. Available online at http://www.who.int/dg/speeches/2014/ebola/en (Accessed 2 August 2014)
2. Centers for Disease Control. Ebola hemorrhagic fever. Available online at http://www.cdc.gov/vhf/ebola/about.html (Accessed 3 August 2014)
3. National Travel Health Network and Centre. Ebola virus disease: West Africa – update. Available online at https://www.nathnac.org/pro/clinical_updates/ebola_westafrica_220714.htm (Accessed 1 August 2014)
4. World Health Organization. West Africa – Ebola virus disease, Update. 2014 Ebola virus disease (EVD) outbreak in West Africa. Travel and transport risk assessment: recommendations for public health authorities and transport sector. Available online at http://www.who.int/ith/updates/20140421/en/ (Accessed 3 August 2014)
5. Kroll D. Do we have any drugs to treat Ebola? Forbes Magazine. Available online at http://www.forbes.com/sites/davidkroll/2014/07/29/ebola-outbreak-fears-will-any-drugs-work (Accessed 3 August 2014)
CHILD HEALTH: Pox, plague, progress and prospects for the future
1. Dow DA. Safeguarding the public health: a history of the New Zealand Department of Health. Wellington: Victoria University Press, 1995.
2. Kennedy RB, Lane JM, Henderson DA et al. Smallpox and vaccinia. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. Elsevier, 2013.
Comment
FROM THE HDC OFFICE: Primary care rising to the challenge of mental illness
1. World Health Organization. The Global Burden of Disease: 2004 Update. Geneva, Switzerland: WHO Press, 2008.
2. Chesney E, Goodwin GM, Fazel S. Risks of all-cause and suicide mortality in mental disorders: a meta-review. World Psychiatry 2014;13:2:153-160.
http://onlinelibrary.wiley.com/doi/10.1002/wps.20128/full
3. Te Pou o Te Whakaaro Nui. June 2014. The Physical health of people with a serious mental illness and/or addiction. An evidence review. Auckland: Te Pou.
http://www.tepou.co.nz/library/tepou/the-physical-health-of-people-with-a-serious-mental-illness-andor-addiction-an-evidence-review
4. World Health Organization. May 2012. Sixty-fifth World Health Assembly. The global burden of mental disorders and the need for a comprehensive, coordinated response from health and social sectors at country level. Geneva: WHO.
http://apps.who.int/gb/ebwha/pdf_files/WHA65/A65_10-en.pdf
5. World Health Organization. 2013. Mental health Action Plan 2013–2020. Geneva: World Health Organization.
http://www.who.int/mental_health/publications/action_plan/en
6. Mental Health Commission. June 2012. Blueprint II Improving Mental Health and Wellbeing for all New Zealanders: How things need to be. Wellington.
7. New Zealand Ministry of Health. Dec 2012. Rising to the Challenge. The Mental health and Addiction Service Development Plan 2012–2017. Wellington.
8. Pharmac. 2013 Annual Report 2012-2013. Wellington.
13 August 2014
Practice
CHILD HEALTH: Undescended testes need repeated checks in infants
1. Ghirri P, Ciulli C, Vuerich M et al. Incidence at birth and natural history of cryptorchidism: a study of 10,730 consecutive male infants. J Endocrinol Invest 2002;25(8):709–15.
2. Snodgrass W, Bush N, Holzer M et al. Current referral patterns and means to improve accuracy in diagnosis of undescended testis. Pediatrics 2011;127(2):e382–88.
3. Boyd HA, Myrup C, Wohlfahrt J et al. Maternal serum alpha-fetoprotein level during pregnancy and isolated cryptorchidism in male offspring. Am J Epidemiol 2006;164(5):478–86.
4. Schnack TH, Zdravkovic S, Myrup C et al. Familial aggregation of cryptorchidism—a nationwide cohort study. Am J Epidemiol 2008;167(12):1453–57.
5. Ferlin A, Zuccarello D, Zuccarello B et al. Genetic alterations associated with cryptorchidism. J Am Med Assoc 2008;300(19):2271–76.
6. Seetharam V, Hameed ZBM, Talengala SB et al. Bilateral cryptorchidism with bilateral synchronous abdominal testicular germ cell tumour. BMJ Case Rep 2014;2014:bcr2013203085.
7. Tekgül S, Dogan HS, Hoebeke P et al. for the European Society for Paediatric Urology/European Association of Urology. Guidelines on paediatric urology, 2014. Available online at http://www.uroweb.org/gls/pdf/23%20Paediatric%20Urology_LR%20March%2025th.pdf
DERMATOLOGY: Isotretinoin for acne is a complex treatment
1. Medsafe. Data sheet, Oratane. Available online at http://www.medsafe.govt.nz/profs/Datasheet/o/oratanecap.pdf
2. Douglas Pharmaceuticals. Oratane: total acne treatment (website). www.oratane.co.nz
3. DermNet New Zealand. Isotretinoin. Available online at www.dermnetnz.org/treatments/isotretinoin.html
MEDICOLEGAL: To treat or report? A question for all doctors
1. The General Medical Council and Sir Roy Meadow [2007] 1 QB 462.
2. Kuiper K. When medical reports become medical evidence: judgments of the Court. N Z Med J 11 April 2014;127:1392. (A useful guideline on these issues.)
3. Medical Council of New Zealand. Non-treating doctors performing medical assessments of patients for third parties. (Paragraph 18: the guideline deals with medical assessments by the patient’s usual doctor – it requires the assessment be “accurate, objective and based on all the available evidence”.) Available online at www.mcnz.org.nz
SPORTS MEDICINE: Does long-term running or walking damage the hip?
1. Williams PT. Effects of running and walking on osteoarthritis and hip replacement risk. Med Sci Sports Exerc 2013;45(7):1292–97.
30 July 2014
Practice
CHILD HEALTH: Food for thought from across the ditch
1. Bing B. Public Health Association of Australia (PHAA) 14th National Immunisation Conference presentation, Melbourne, 2014. Inpatients cost and hospital service use for children admitted with invasive meningococcal disease.
2. Chiu C. Public Health Association of Australia (PHAA) 14th National Immunisation Conference presentation, Melbourne, 2014. Epidemiological basis for meningococcal B vaccine target age group recommendations in Australia.
3. Australian Government. Department of Health. Australian Meningococcal Surveillance Programme annual report. Available online at http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-pubs-annlrpt-menganrep.htm
4. Perrett K. Public Health Association of Australia (PHAA) 14th National Immunisation Conference presentation, Melbourne, 2014. Antibody persistence in Australian adolescents following meningococcal C conjugated vaccination in childhood.
5. Liu B. Public Health Association of Australia (PHAA) 14th National Immunisation Conference presentation, Melbourne, 2014. The National HPV Vaccination program: seven years on.
6. Hill V. Public Health Association of Australia (PHAA) 14th National Immunisation Conference presentation, Melbourne, 2014. Severity of gastroenteritis in South Australian children hospitalised with rotavirus before and after rotavirus immunisation introduction.
7. Buttery JP, Lambert SB, Grimwood K, et al. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia’s national childhood vaccine schedule. Pediatr Infect Dis J 2011;30(1 Suppl):S25-9. [Erratum appears in Pediatr Infect Dis J 2011 Oct; 30(10):916]
ELDER HEALTH: Music and memory help to stall cognitive deficits
1. Verghese J, Lipton RB, Katz MJ et al. Leisure activities and the risk of dementia in the elderly. N Engl J Med 2003;348(25):2508–16.
2. Raglio A, Bellelli G, Traficante D et al. Efficacy of music therapy in the treatment of behavioral and psychiatric symptoms of dementia. Alzheim Dis Assoc Disord 2008;22(2):158–62.
3. Chang F-Y, Huang H-C, Lin K-C et al. The effect of a music programme during lunchtime on the problem behaviour of the older residents with dementia at an institution in Taiwan. J Clin Nurs 2010 Apr;19(7–8):939–48.
OCCUPATIONAL HEALTH: Humans must dance to the circadian rhythm
1. Goel N, Van Dongen HPA, Dinges DF. Circadian rhythms in sleepiness, alertness, and performance. In: Principles and practice of sleep medicine. 5th edition. Kryger MH, Roth T, Dement WC (eds). Philadelphia: Saunders, 2011.
HOW TO TREAT: Shingles
1. Ministry of Health. Immunisation Handbook. Wellington: Ministry of Health, 2014.
2. Dworkin RH et al. Recommendations for the management of herpes zoster. Clin Infect Dis 2007;44:S1–26.
3. Forbes HJ et al. Quantification of risk factors for herpes zoster: population based case control study. BMJ 2014;348:g2911 doi: 10.1136/bmj.g2911 (Published 13 May 2014).
4. Centers for Disease Control. Prevention of herpes zoster: recommendations of the ACIP. MMWR 2008;57(05):1–30.
5. Katz J, Melzack R. Measurement of pain. Surg Clin N Am 1999;79:231–52.
6. Dworkin RH et al. In: Herpes zoster and PHN. 2nd edn. Amsterdam: Elsevier, 2001. pp39–64.
7. Oxman MN et al. A vaccine to prevent herpes zoster and post herpetic neuralgia in older adults. N Engl J Med 2005;352:2271–84.
8. Yawn BP et al. A population based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 2007;82:1341–49.
9. Langan SM et al. Risk of stroke following herpes zoster: a self controlled case series study. Clin Infect Dis (Advance publication 2 April 2014).
10. Kang J et al. Increased risk of stroke after a herpes zoster attack: a population-based follow-up study. Stroke 2009;40:3443–48.
11. Lin HC et al. Herpes zoster ophthalmicus and the risk of stroke: a population-based follow-up study. Neurology 2010;74:792–97.
12. Hope-Simpson RE. Herpes zoster in general practice: post herpetic neuralgia. J R Coll Gen Pract 1975;25:571–75.
13. MacIntyre CR et al. Increasing incidence of herpes zoster in older Australians (abstract). Presented at the 14th National Immunisation Conference, Melbourne, June 2014.
14. Cohen JI. Herpes zoster. N Engl J Med 2013;369:255–63.
15. Yan EY et al. Management of herpes zoster and post-herpetic neuralgia. Am J Clin Dermatol 2013;14:77–85.
16. The diagnosis and management of herpes zoster and its complications. Best Pract 2014;59:37–43.
17. Medsafe New Zealand. Zovirax New Zealand medicine data sheet.
18. Medsafe New Zealand. Valaciclovir New Zealand medicine data sheet.
19. McKendrick MW et al. Oral acyclovir in acute herpes zoster. Br Med J (Clin Res Ed) 1986;293:1529–32.
20. Chen N et al. Antiviral treatment for preventing post herpetic neuralgia. Cochrane database systemic review 2014;2:CD006866.
21. Whitley RJ et al. Acyclovir with and without prednisone for the treatment of herpes zoster. Ann Intern Med 1996;125:376–83.
22. Wood MJ et al. A randomized trial of acyclovir for 7 days or 21 days with or without prednisone for treatment of acute herpes zoster. N Engl Med J 1994;330:896–900.
23. Dworkin RH et al. A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster. Pain 2009;142:209–17.
24. Berry JD, Petersen KL. A single dose of gabapentin reduces acute pain and allodynia in patients with herpes zoster. Neurology 2005;65:444–47.
25. Gilron I et al. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial. Lancet 2009;374:1252–61.
26. Bowsher D. The effects of pre-emptive treatment of post herpetic neuralgia with amitriptyline: a randomised double blind placebo controlled study. J Pain Sympt Manag 1997;13:327–31.
27. Schmader KE et al. Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50–59 years. Clin Infect Dis 2012;54(7):922–28.
16 July 2014
Practice
MEDICOLEGAL: Five things to learn from other doctors' impropriety
1. Medical Practitioners Disciplinary Tribunal Decision 0064C
2. TV3. Third Degree (an examination of how flags were missed in the James Parker case). Available on demand at http://www.3news.co.nz/James-Parker-a-parasitic-paedophile/tabid/1773/articleID/301196/Default.aspx
3. New Zealand Lawyers and Conveyancers Disciplinary Tribunal (Canterbury Western Standards Committee) v C Horsley [2014] NZLCDT 9.
4. ERO report on Pamapuria School, 2006.
5. Health Practitioners Disciplinary Tribunal Decision 591/MED13/258P.
6. Health Practitioners Disciplinary Tribunal Decision 557/MED12/230P.
7. Health Practitioners Disciplinary Tribunal Decision 557/MED12/230.
CLINICAL COMMENT: Sticky messages for success in reaching difficult patients
1. Heath C, Heath D. Made to stick: why some ideas survive and others die. New York: Random House, 2008.
2. Janes R, Titchener J, Pere J et al. Understanding barriers to glycaemic control from the patient’s perspective. J Prim Health Care 2013;5(2):114–22.
SEXUAL HEALTH: Opportunistic screening for HIV, hepatitis and syphilis
1. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Sep 22, 2006:55(RR14);1–17.
2. Terrault NA et al. Sexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV Partners Study. Hepatology 2013;57(3):881–89.
3. Witt MD et al. Incident hepatitis C virus infection in men who have sex with men: a prospective cohort analysis, 1984–2011. Clin Infect Dis 2013;57(1):77–84.
4. Kahn J. Preventing hepatitis A and hepatitis B virus infections among men who have sex with men. Clin Infect Dis 2002;35:1382–87.
5. Neukam K et al. Chronic hepatitis E in HIV patients: rapid progression to cirrhosis and response to oral ribavirin. Clin Infect Dis 2013;57(3):465–68.
SPORTS MEDICINE: Concussion in 2014: a word from the team room
1. Martland HS. Punch drunk. JAMA 1928;91:1103–07.
2. Randolph C. Is chronic traumatic encephalopathy a real disease? Curr Sports Med Rep 2014;13(1):33–37.
3. Lyall J. Scientist blasts concussion hysteria. 19 June 2014. Available online at http://www.planetrugby.com/story/0,25883,3551_9354113,00.html
4. Tana Umaga, Wellington Hurricanes v Canterbury Crusaders. YouTube video available online at http://www.youtube.com/watch?v=31-LvRLWGz4
5. Gardner A1, Iverson GL, McCrory P. Chronic traumatic encephalopathy in sport: a systematic review. Br J Sports Med 2014;48:84–90.
FIRST TIME: Telehealth - remote consulting needs some preparation
1. Statement on telehealth. Medical Council of New Zealand, June 2013. Available online at http://www.mcnz.org.nz/assets/News-and-Publications/Statement-on-telehealthv3.pdf
2. Alexander Graham Bell. Wikiquote. Available online at http://en.wikiquote.org/wiki/Alexander_Graham_Bell
3. Telehealth: guidelines and practical tips. The Royal Australasian College of Physicians. Available online at http://www.racptelehealth.com.au/wp-content/uploads/2013/02/Telehealth-Guidelines-and-Practical-Tips.pdf
4. Smith CM. Origin and uses of primum non nocere – above all, do no harm! J Clin Pharmacol 2005;45(4):371–77.
5. Health and Disability Commissioner. Health and Disability Commissioner Act, code of rights. Available online at http://www.hdc.org.nz/the-act--code/the-code-of-rights
6. Medicare Local. Telehealth – tips for a video consultation. Available online at http://mrnwm-ml.org.au/telehealth-tips-for-a-video-consultation/
7. Neighbour RH. The inner consultation – how to develop an effective and intuitive consulting style. Lancaster: Kluwer Academic Press, 1987.
2 July 2014
Practice
TRAVEL MEDICINE: Motor mightier than the microbe: danger on foreign roads
1. Boyer S. Tourist drivers; the truth about crashes. New Zealand Herald, 7 June 2014
2. WHO Report. Global status report on road safety; time for action. Geneva: World Health Organization, 2009. Available online at www.who.int/violence_injury_prevention/road_safety_status/2009/ (Accessed 3 June 2014)
3. WHO Report. Global status report on road safety. Geneva: World Health Organization, 2013. Available online at www.who.int/violence_injury_prevention/road_safety_status/2013/en/ (Accessed 9 June 2014)
4. WHO Report. Road traffic injury prevention training manual. Geneva: World Health Organization, 2006. Available online at http://whqlibdoc.who.int/publications/2006/9241546751_eng.pdf (Accessed 9 June 2014)
5. CDC Report. International road safety. Available online at wwwnc.cdc.gov/travel/page/road-safety (Accessed 10 June 2014)
HOW TO TREAT: bowel cancer
1. Newstead G. Bowel cancer: why raising awareness is our best hope. The Age (Melbourne), 2 April 2014. Available online at http://www.theage.com.au/comment/bowel-cancer-why-raising-awareness-is-our-best-hope-20140402-zqpoj.html
2. Barry D. A journey into my colon – and yours. Miami Herald, 2 Nov 2009. Available online at (Humour: a comedian’s colonoscopy)
http://www.miamiherald.com/2009/02/11/427603/dave-barry-a-journey-into-my-colon.html
3. Ministry of Health. Cancer: historical summary 1948–2010. Wellington: Ministry of Health, 30 August 2013. Available online at
http://www.health.govt.nz/publication/cancer-historical-summary-1948-2010
4. New Zealand Guidelines Group. NZGG (publications by subject). http://www.nzgg.org.nz
5. National Guideline Clearinghouse. Agency for Healthcare Research and Quality, US Department of Health & Human Services. http://www.guideline.gov
6. Colorectal Surgical Society of Australia and New Zealand. http://www.cssanz.org/
7. New Zealand Familial Gastrointestinal Cancer Service. http://www.nzfgcs.co.nz
18 June 2014
Practice
CHILD HEALTH: Antibiotics for children: how long is long enough?
1. Kerrison C, Riordan FAI. How long should we treat infection for? Arch Dis Child Educ Pract Ed 2013;98:136–40.
2. Haider BA, Lassi ZS, Bhutta ZA et al. Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months (Review). Cochrane Database Syst Rev 2008; (2): CD005976.
3. Michael M, Hodson EM, Craig JC et al. Short versus standard duration oral antibiotic therapy for acute urinary tract infection in children (Review). Cochrane Database Syst Rev 2003; (1): CD003966.
DERMATOLOGY: With eczema, sensitive skin is a lifelong problem
1. The eczema area and severity index (EASI) score tool. More information available online at http://dermnetnz.org/dermatitis/easi.html
2. The scoring atopic dermatitis (SCORAD) clinical tool. More information available online at http://dermnetnz.org/dermatitis/scorad.html
3. Dermatology Life Quality Index (DLQI). Cardiff University. Available online at http://www.dermatology.org.uk/quality/quality-life.html
4. Guidelines for the management of atopic dermatitis. A summary of current British and American guidelines, with relevance to the treatment of atopic dermatitis in New Zealand. Available online at http://www.dermnetnz.org/doctors/guidelines/atopic-guidelines.html
FIRST TIME: Be clear on values, principles of an alliance before joining
1. State Government Victoria, Department of Treasury and Finance. Alliance and traditional contracting. Available online at http://www.dtf.vic.gov.au/Infrastructure-Delivery/Alliance-and-traditional-contracting
2. DHB Shared Services. Available online at http://www.dhbsharedservices.health.nz/Site/PSAAP/default.aspx
MEDICOLEGAL: Of bullies, bullying and harassment: a fireside chat
1. Farrington, D. Understanding and preventing bullying. In: Tonry M (ed.), Crime and justice: a review of research. Vol. 17. Chicago and London: University of Chicago Press, 1993.
2. Helen Cull QC. The review of processes concerning adverse medical events. “The Cull Report”, 2001.
3. Blackford v Cullen, Decision No 26-00, CRT 12-00. An example where costs of $6185.00 (close to actual costs) sought on behalf of my client were awarded against a patient.
4. Slavich v Judicial Conduct Commissioner [2013] NZHC 1688.
5. Z v Complaints Assessment Committee [2006] NZAR 146.
SEXUAL HEALTH: Opportunistic screening for common bacterial STIs
1. Public health surveillance. The Institute of Environmental & Scientific Research (ESR) annual report 2012. STI surveillance. Available online at https://surv.esr.cri.nz/surveillance/annual_sti.php
2. Chlamydia management guidelines. Wellington: Ministry of Health, 2008. Available online at http://www.health.govt.nz/publication/chlamydia-management-guidelines
CLINICAL COMMENT: To some patients, the future is a very distant promise
1. Pound P, Britten N, Morgan M et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med 2005;61(1):133–55.
2. Dalewitz J, Khan N, Hershey CO. Barriers to control of blood glucose in diabetes mellitus. Am J Med Qual 2000;15(1):16–25.
3. Ariely D. The upside of irrationality: the unexpected benefits of defying logic at work and home. London: Harper, 2010. p334. [The quote is at the section at the end of the book titled ‘PS’, About the Author, p4.]
4. Rodriguez K. Intrinsic and extrinsic factors affecting patient engagement in diabetes self-management: perspectives of a certified diabetes educator. Clin Ther 2013;35:170–78.
4 June 2014
Practice
CHILD HEALTH: Anti-immunisation rhetoric hasn’t changed its spots
1. Goodyear-Smith F, Petousis-Harris H, Van Laar C et al. Immunization in the print media: perspectives presented by the press. J Health Communication 2007;12(8):759–70.
2. Turner NM, York DG, Petousis-Harris HA. The use and misuse of media headlines: lessons from the MeNZB™ immunisation campaign. N Z Med J 13 Mar 2009;122(1291).
21 May 2014
Practice
CHILD HEALTH: Femoral pulse checks essential at infants' six-week visit
1. Punukollu M, Harnden A, Tulloh R. Coarctation of the aorta in the newborn. Br Med J 2011 Nov 16;343 d6838. doi: 10.1136/bmj.d6838.
2. Ing FF, Starc TJ, Griffiths SP et al. Early diagnosis of coarctation of the aorta in children: a continuing dilemma. Pediatrics 1996;98(3 Pt 1):378–82.
3. Ward KE, Pryor RW, Matson JR et al. Delayed detection of coarctation in infancy: implications for timing of newborn follow-up. Pediatrics 1990;86(6):972–76.
4. Wren C, Richmond S, Donaldson L. Presentation of congenital heart disease in infancy: implications for routine examination. Arch Dis Child Fetal Neonatal Ed 1999;80(1):F49–53.
5. Gregory J, Emslie A, Wyllie J et al. Examination for cardiac malformations at six weeks of age. Arch Dis Child Fetal Neonatal Ed 1999;80(1):F46–48.
6. Chang R-KR, Gurvitz M, Rodriguez S. Missed diagnosis of critical congenital heart disease. Arch Pediatr Adolesc Med 2008;162(10):969–74.
DERMATOLOGY: Psoriasis is a systemic disease that requires monitoring
1. Raychaudhuri SK, Maverakis E, Raychaudhuri SP. Diagnosis and classification of psoriasis. Autoimmun Rev 2014 Apr–May;13(4–5):490–95. doi:10.1016/j.autrev.2014.01.008. Epub 2014 Jan 13.
2. Griffiths CE, Christophers E, Barker JN et al. A classification of psoriasis vulgaris according to phenotype. Br J Dermatol 2007 Feb;156(2):25–62.
3. DermNet New Zealand Trust. Ngan V. Guidelines for the management of psoriasis. DermNet NZ, 2014. Available online at http://www.dermnetnz.org/doctors/guidelines/psoriasis-guidelines.html
MEDICOLEGAL: Consent to disclosure -- is that for all patient information?
1. Powell v ACC [2014] NZACC 89 and K v ACC [2014] NZACC 90.
2. Paragraph 13, Powell v ACC (supra).
3. Privacy Commissioner. Collection of medical notes by insurers – inquiry by the Privacy Commissioner. June 2009. Available online at http://www.privacy.org.nz/news-and-publications/commissioner-inquiries/collection-of-medical-notes-by-insurers-inquiry-by-the-privacy-commissioner/
4. Medical Council of New Zealand. Non-treating doctors performing medical assessments of patients for third parties. December 2010. Available online (pdf) at http://www.mcnz.org.nz/assets/News-and-Publications/Statements/Non-treating-doctors.pdf
SPORTS MEDICINE: Navigating return to play guidelines in general practice
1. Matheson GO, Shultz R, Bido J et al. Return-to-play decisions: are they the team physician’s responsibility? Clin J Sports Med 2011;21(1):25–30.
2. Czuppon S, Racette BA, Klein SE et al. Variables associated with return to sport following anterior cruciate ligament reconstruction: a systematic review. Br J Sports Med 2014;48:356–64.
7 May 2014
Practice
23 April 2014
Practice
FIRST TIME: Soaring obesity prevalence is too rapid to be genetic
1. Ministry of Health. New Zealand Health Survey: annual update of key findings 2012/13.
2. Cochrane Database Syst Rev. 2012 Jan 18;1:CD006219. doi:10.1002/14651858.CD006219.pub3.
3. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD003641. doi:10.1002/14651858.CD003641.pub3.
4. Cochrane Database Syst Rev. 2004;(3):CD004094.
9 April 2014
Practice
How to Treat
HOW TO TREAT: Substance abuse
1.Rhem J, Taylor B, Room R. Global burden of disease from alcohol, illicit drugs and tobacco. Drug Alcohol Rev 2006;25:503-13.
2.Global Commission on Drug Policy, June 2011. War on drugs. Report of the Global Commission on Drug Policy.
3.Ministry of Health. Drug use in New Zealand: key results of the 2007/08 New Zealand Alcohol and Drug Use Survey. Wellington: Ministry of Health, 2010.
4.Wilkins C, Sweetsur P, Smart B et al. Recent trends in illegal drug use in New Zealand, 2006-2010. Findings from the 2006, 2007, 2008, 2009, 2010 and 2011 Illicit Drug Monitoring System (IDMS). Auckland: Social and Health Outcomes Research and Evaluation (SHORE), School of Public Health, Massey University, 2012.
5.International Narcotics Control Board. Report of the International Narcotics Control Board for 2006. Vienna: INCB, 2006.
6.Update on oxycodone. What can primary care do about the problem? Best Pract J 2012;44:8-16.
7.American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th Edition). Washington, DC: American Psychiatric Association, 2013.
8.McAvoy BR. Addiction and addiction medicine: exploring opportunities for the general practitioner. MJA 2008;189:115-117.
9.Hindler C, Nazareth I, King M et al. Drug users' views on general practitioners. BMJ 1995;310:302.
10.Best D, Day E, Morgan B. Addiction careers and the natural history of change. Research briefing: 20. London: National Treatment Agency for Substance Misuse, 2006.
11.Anthony JC, Warner LA, Kessler RC. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the National Comorbidity Survey. Exper Clin Psychopharmacol 1994;2:244-68.
12.US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration. 1999 National Household Survey on Drug Abuse. Washington, DC: HHS, 2000.
13.Kaya CY, Tugai Y, Filar JA et al. Heroin users in Australia: population trends. Drug Alcohol Rev 2004;23:107-16.
14.Robinson G. Prescription drug misuse. How to identify and manage drug seekers. Best Pract J 2008;16:18-23.
15.Friese G, Wojciehoski R, Friese A. Drug seekers: do you recognise the signs? Emerg Med Serv 2005;34:64-67.
16.Longo L, Parran T, Johnson B et al. Addiction: part II. Identification and management of drug-seeking patients. Am Fam Physician 2006;61:2401-08.
17.Carr N. "I just want some Valium, Doc". Am Fam Physician 1998;27:817-21.
18.Latt N et al. Oxford specialist handbooks. Addiction medicine. Oxford: Oxford University Press, 2009.
19.McCormick R. Treating drug addiction in general practice. N Z Fam Physician 2000;27(4):27-29.
20.Matua Raki. Substance withdrawal management: guidelines for medical and nursing practitioners in primary health, specialist addiction, custodial and general hospital settings. Wellington: Matua Raki, 2011.
21.National Centre for Education and Training on Addiction (NCETA) consortium. Alcohol and other drugs: a handbook for health professionals. Canberra: Department of Health and Ageing, 2004.
22.Matua Raki. Substance withdrawal management: guidelines for addiction and allied practitioners. Wellington: Matua Raki, 2012.
23.Friedman J et al. "Grievous bodily harm": gamma hydroxybutyrate abuse leading to a Wernicke-Korsakoff syndrome. Neurology 1996;46:469-71.
26 March 2014
Practice
MEDICOLEGAL: In retrospect: to note, or not to note, the notes?
1. Health and disability commissioner. Decision 10HDC01250
2. Health and disability commissioner. Decision 12HDC00281
FROM THE LAB: Provoking factors and gender sway anticoagulation duration
1. Executive summary. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012 Feb;141(2 Suppl).
2. Pomp ER et al. Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. Br J Haematol 2007 Oct;139(2):289-96.
3. Kearon C. McMaster University, Hamilton, Canada (presentation). D-dimer to select patients with a first unprovoked venous thromboembolism (VTE) who have anticoagulants stopped at 3-7 months or have treatment continued indefinitely: a multicentre management study. International Society of Thrombosis and Haemostasis Congress, Amsterdam, 2013.
12 March 2014
Comment
FROM THE HDC'S OFFICE: Aged care - ensuring the right intervention at the right time
1. http://www.stats.govt.nz/Census/2013-census/profile-and-summary-reports/quickstats-about-national-highlights/age-and-sex.aspx
2. 11HDC00471. Available at www.hdc.org.nz
3. 12HDC00555. Available at www.hdc.org.nz
Practice
TRAVEL: Destination Oceania: pestilence in paradise?
1. United Nations. Classification of countries by major region and area of the world. Available online at http://esa.un.org/unpd/wup/CD-ROM_2009/WPP2009_DEFINITION_OF_MAJOR_AREAS_AND_REGIONS.pdf
2. Map of Oceania showing the location of the island nations can be accessed online at http://www.worldatlas.com/webimage/countrys/oceania/pf.htm
3. Leder K, Torresi J, Shaw M. Oceania. In: Petersen E, Chen LH, Schlagenhauf P, editors. A geographic guide to infectious diseases. First edition. John Wiley & Sons, 2011;341-59.
4. Leder K, Torresi J, Shaw M. Australia and New Zealand. In: Petersen E, Chen LH, Schlagenhauf P, editors. A geographic guide to infectious diseases. First edition. John Wiley & Sons, 2011;326-40.
How to Treat
HOW TO TREAT: Endometriosis
1. Adamson GD, Kennedy SH, Hummelshoj L. Creating solutions in endometriosis: global collaboration through the World Endometriosis Research Foundation. J Endometriosis 2010;2:3-6.
2. Nnoaham KE, Hummelshoj L, Webster P, et al. for the World Endometriosis Research Foundation Global Study of Women's Health consortium. Impact of endometriosis on quality of life and work productivity: a multi-center study across 10 countries. Fertil Steril 2011;96:366-73.
3. Nnoaham KE, Hummelshoj L, Kennedy SH, et al. for the World Endometriosis Research Foundation Women's Health Symptom Survey consortium. Developing symptom-based predictive models of endometriosis as a clinical screening tool: results from a multicenter study. Fertil Steril 2012;98:692-701.
4. Johnson NP, Hummelshoj L for the World Endometriosis Society Montpellier consortium. Consensus on current management of endometriosis. Hum Reprod 2013;28:1552-68. Available online at http://humrep.oxfordjournals.org/content/28/6/1552.full.pdf+html with supplementary data for this guideline also available at http://humrep.oxfordjournals.org/content/28/6/1552/suppl/DC1
5. Sesti F, Pietropolli A, Capozzolo T, et al. Hormonal suppression treatment or dietary therapy versus placebo in the control of painful symptoms after conservative surgery for endometriosis stage III-IV: a randomized comparative trial. Fertil Steril 2007;88:1541-47.
6. Johnson NP, Farquhar CM, Hadden, et al. The FLUSH Trial - flushing with lipiodol for unexplained (and endometriosis-related) subfertility by hysterosalpingography: a randomised trial. Hum Reprod 2004;19:2043-51.
7. Court KA, Dare AJ, Weston-Webb M, et al. Establishment of lipiodol as a fertility treatment - prospective study of the complete innovative treatment data set. Aust N Z J Obstet Gynaecol 2013 Sep 13. doi: 10.1111/ajo.12124. [Epub ahead of print]
8. Johnson NP. Review of lipiodol treatment for infertility - an innovative treatment for endometriosis-related infertility? Aust N Z J Obstet Gynaecol 2013 Oct 19. doi: 10.1111/ajo.12141. [Epub ahead of print]
26 February 2014
Practice
CHILD HEALTH: Red reflex at the six-week check must not be missed
1. Dalton M. Six-week check not just a medical. New Zealand Doctor, 12 September 2012, p27.
2. Public Health England. Welcome to the NHS newborn and infant physical examination screening programme. 18 November 2013. Retrieved from http://newbornphysical.screening.nhs.uk/
3. Rahi JS, Dezateux C. Measuring and interpreting the incidence of congenital ocular anomalies: lessons from a national study of congenital cataracts in the UK. Invest Ophthalmol Vis Sci 2001;42:1444-48.
4. Bashour M. Congenital cataract clinical presentation. Medscape, 2012. Retrieved from http://emedicine.medscape.com/article/1210837-clinical#a0218 on 18 November 2013
5. Tuli SY, Giordano BP, Kelly M, et al. Newborn with an absent red reflex. J Pediatr Health Care 2013;(27)1:51-55.
6. Rahi JS, Dezateux C. National cross-sectional study of detection of congenital and infantile cataract in the United Kingdom: role of childhood screening and surveillance. BMJ 1999;318:362-65.
7. Sotomi O, Ryan CA, O'Connor G, et al. Have we stopped looking for a red reflex in newborn screening? Ir Med J 2007;100:398-400.
8. Birch EE, Cheng C, Stager DR Jr, et al. The critical period for surgical treatment of dense congenital bilateral cataracts. JAAPOS 2009;13:67-71.
9. Russell HC, McDougall V, Dutton GN. Congenital cataract. BMJ 2011;342:d3075.
MEDICOLEGAL: When the tail wags the dog in consultations
1. Medical Council of New Zealand. Good Prescribing Practice, April 2010. Available online at www.mcnz.org.nz
2. Section 29, Medicines Act 1981.
3. Workshops available from organisations such as Connect (worth considering) www.connectcomm.co.nz
4. Medical Council of New Zealand. Ending a doctor-patient relationship, March 2011. Available online at www.mcnz.org.nz
12 February 2014
Practice
HEARTBEAT: Insurance broker needs more convincing of her risks
1. Hoff JA, Chomka EV, Krainik AJ, et al. Age and gender distributions of coronary artery calcium detected by electron beam tomography in 35,246 adults. Am J Cardiol 2001;87:1335-39.
2. American College of Cardiology/American Heart Association. Joint guidelines on Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults, Lifestyle Management to Reduce Cardiovascular Risk, Management of Overweight and Obesity in Adults, and Assessment of Cardiovascular Risk, 2013. All four guidelines available online at: http://my.americanheart.org/professional/StatementsGuidelines/ByTopic/TopicsA-C/ACCAHA-Joint-Guidelines_UCM_321694_Article.jsp
3. Perk J, De Backer G, Gohlke H, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2012;33:1635-1701.
How to Treat
HOW TO TREAT: Schizophrenia in primary care
1. Tiihonen J, Lönnqvist J, Wahlbeck K et al. Eleven-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet 2009;9690:620-27.
2. Saha S, Chant S, Welham J et al. A systematic review of the prevalence of schizophrenia. PLoS Med 2005;2(5):e141.
3. Kake RT, Arnold R, Ellis P. Estimating the prevalence of schizophrenia amongst New Zealand Maori: a capture-recapture approach. Aust N Z J Psychiatry 2008;42:941-49.
4. SANE. Schizophrenia costs. An analysis of the burden of schizophrenia. Melbourne: SANE Australia, 2002.
5. Liddle PF. The multidimensional phenotype of schizophrenia. In: Tamminga CA, ed. Schizophrenia in a molecular age. Washington DC: American Psychiatric Press, 1999.
6. Allen NC, Bagade S, McQueen MB et al. Systematic meta-analysis and field synopsis of genetic association studies in schizophrenia. Nat Genet 2008;40:827-34.
7. Kapur S. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology and physiology in schizophrenia. Am J Psychiatry 2003;160:13-23.
8. Coleman M, Gillberg C. The schizophrenias. A biological approach to the schizophrenia spectrum disorders. New York: Springer, 1996.
9. Marshall M, Rathbone J. Early intervention for psychosis. 2011 Cochrane Database Systematic Reviews (6): CD00 4718.
10. McGlashan TH, Evensen J, Haahr U et al. Early detection and intervention (EDI) in first episode psychosis: can it increase the chance for full recovery? 10-year findings. Schizophrenia Bull 2011;327(Suppl 1):273-74.
11. Larsen, TK, Melle I, Auestad B et al. Early detection of psychosis: positive effects on 5-year outcome. Psychological Med 2011;41:1461-69.
12. Amador X. I am not sick. I don't need help! New York: Vida Press, 2007.
13. Leap Institute. New York. www.leapinstitute.org
14. Davis J, Chen N, Glick I. A meta-analysis of the efficacy of second generation antipsychotic. Arch Gen Psychiatry 2003;60:553-64.
15. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. Available online at: https://www.ranzcp.org/Files/ranzcp-attachments/Resources/Publications/CPG/Clinician/CPG_Clinician_Full_Schizophrenia-pdf.aspx
16. Kinon BJ, Chen L, Ascher-Svanum H et al. Predicting response to antipsychotics based on early response in the treatment of schizophrenia. Schizophrenia Res 2008;102:230-40.
17. Takefumi S, Hiroyuki U, Koichiro W et al. How effective is it to sequentially switch among olanzapine, quetiapine and risperidone? A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical setting. Psychopharmacol 2007;195:285-95.
18. Huxley NA, Redall M, Sederer L. Psychosocial treatments in schizophrenia: a review of the past 20 years. J Nerv Mental Dis 2000:188:187-201.
19. Pharoah F, Rathbone J, Mari J et al. Family interventions for schizophrenia. The Cochrane Library, Issue 1. Chichester: Wiley, 2004.
20. Pekkla E, Merinder L. Psychoeducation for schizophrenia. The Cochrane Library, Issue 1. Chichester: Wiley, 2004.
21. Cormac I, Jones C, Campbell C et al. Cognitive therapy for schizophrenia. The Cochrane Library, Issue 1. Chichester: Wiley, 2004.
22. Wykes T, Spaulding WD. Thinking about the future cognitive remediation therapy. What works and could we do better? Schizophrenia Bull 2011:37(Suppl 2):80-90.
23. Kopelowicz A, Liberman RP, Zaeante R. Psychosocial treatments for schizophrenia. In: Nathan PE, Gorman JM, eds. A guide to treatments that work. 2nd edition. London: Oxford University Press, 2002; 201-28.
24. Crowther R, Marshall M, Bond GR et al. Vocational rehabilitation for people with severe mental illness. The Cochrane Library, Issue 1. Chichester: Wiley, 2004.
25. The early diagnosis and management of psychosis: a booklet for general practitioners. Melbourne: Early Psychosis Prevention and Intervention Centre, 2002. Available online at: http://eppic.org.au/node/172
Otolaryngologist, head and neck surgeon Francis T. Hall discusses the evaluation of thyroid nodules, which primarily aims to determine the likelihood of malignancy. He then reviews the treatment of thyroid nodules and thyroid cancer, including recent advances in management
![Barbara Fountain, editor of New Zealand Doctor Rata Aotearoa, and Paul Hutchison, GP and senior medical clinician at Tāmaki Health [Image: Simon Maude]](/sites/default/files/styles/thumbnail_cropped_100/public/2025-03/Barbara%20Fountain%2C%20editor%20of%20New%20Zealand%20Doctor%20Rata%20Aotearoa%2C%20and%20Paul%20Hutchison%2C%20GP%20and%20senior%20medical%20clinician%20at%20T%C4%81maki%20Health%20CR%20Simon%20Maude.jpg?itok=-HbQ1EYA)
![Lori Peters, NP and advanced health improvement practitioner at Mahitahi Hauora, and Jasper Nacilla, NP at The Terrace Medical Centre in Wellington [Image: Simon Maude]](/sites/default/files/styles/thumbnail_cropped_100/public/2025-03/2.%20Lori%20Peters%2C%20NP%20and%20advanced%20HIP%20at%20Mahitahi%20Hauora%2C%20and%20Jasper%20Nacilla%2C%20NP%20at%20The%20Terrace%20Medical%20Centre%20in%20Wellington%20CR%20Simon%20Maude.jpg?itok=sUfbsSF1)
![Ministry of Social Development health and disability coordinator Liz Williams, regional health advisors Mary Mojel and Larah Takarangi, and health and disability coordinators Rebecca Staunton and Myint Than Htut [Image: Simon Maude]](/sites/default/files/styles/thumbnail_cropped_100/public/2025-03/3.%20Ministry%20of%20Social%20Development%27s%20Liz%20Williams%2C%20Mary%20Mojel%2C%20Larah%20Takarangi%2C%20Rebecca%20Staunton%20and%20Myint%20Than%20Htut%20CR%20Simon%20Maude.jpg?itok=9ceOujzC)
![Locum GP Helen Fisher, with Te Kuiti Medical Centre NP Bridget Woodney [Image: Simon Maude]](/sites/default/files/styles/thumbnail_cropped_100/public/2025-03/4.%20Locum%20GP%20Helen%20Fisher%2C%20with%20Te%20Kuiti%20Medical%20Centre%20NP%20Bridget%20Woodney%20CR%20Simon%20Maude.jpg?itok=TJeODetm)
![Ruby Faulkner, GPEP2, with David Small, GPEP3 from The Doctors Greenmeadows in Napier [Image: Simon Maude]](/sites/default/files/styles/thumbnail_cropped_100/public/2025-03/5.%20Ruby%20Faulkner%2C%20GPEP2%2C%20with%20David%20Small%2C%20GPEP3%20from%20The%20Doctors%20Greenmeadows%20in%20Napier%20CR%20Simon%20Maude.jpg?itok=B0u4wsIs)
![Rochelle Langton and Libby Thomas, marketing advisors at the Medical Protection Society [Image: Simon Maude]](/sites/default/files/styles/thumbnail_cropped_100/public/2025-03/6.%20Rochelle%20Langton%20and%20Libby%20Thomas%2C%20marketing%20advisors%20at%20the%20Medical%20Protection%20Society%20CR%20Simon%20Maude.jpg?itok=r52_Cf74)
![Specialist GP Lucy Gibberd, medical advisor at MPS, and Zara Bolam, urgent-care specialist at The Nest Health Centre in Inglewood [Image: Simon Maude]](/sites/default/files/styles/thumbnail_cropped_100/public/2025-03/7.%20Specialist%20GP%20Lucy%20Gibberd%2C%20medical%20advisor%20at%20MPS%2C%20and%20Zara%20Bolam%2C%20urgent-care%20specialist%20at%20The%20Nest%20Health%20Centre%20in%20Inglewood%20CR%20Simon%20Maude.jpg?itok=z8eVoBU3)
![Olivia Blackmore and Trudee Sharp, NPs at Gore Health Centre, and Gaylene Hastie, NP at Queenstown Medical Centre [Image: Simon Maude]](/sites/default/files/styles/thumbnail_cropped_100/public/2025-03/8.%20Olivia%20Blackmore%20and%20Trudee%20Sharp%2C%20NPs%20at%20Gore%20Health%20Centre%2C%20and%20Gaylene%20Hastie%2C%20NP%20at%20Queenstown%20Medical%20Centre%20CR%20Simon%20Maude.jpg?itok=Z6u9d0XH)
![Mary Toloa, specialist GP at Porirua and Union Community Health Service in Wellington, Mara Coler, clinical pharmacist at Tū Ora Compass Health, and Bhavna Mistry, specialist GP at Porirua and Union Community Health Service [Image: Simon Maude]](/sites/default/files/styles/thumbnail_cropped_100/public/2025-03/9.%20Mary%20Toloa%2C%20Porirua%20and%20Union%20Community%20Health%20Service%20in%20Wellington%2C%20Mara%20Coler%2C%20T%C5%AB%20Ora%20Compass%20Health%2C%20and%20Bhavna%20Mistry%2C%20PUCHS%20CR%20Simon%20Maude.jpg?itok=kpChr0cc)
